targetId,strataId,cohortId,cohortType,name
1001,1,1001000011,TwS,Hydroxychloroquine  with Full 30-day follow up
1002,1,1002000011,TwS,Hydroxychloroquine + Azithromycin  with Full 30-day follow up
1003,1,1003000011,TwS,Hydroxychloroquine + Fluoroquinolones with Full 30-day follow up
1004,1,1004000011,TwS,Hydroxychloroquine + Amoxicillin with Full 30-day follow up
1005,1,1005000011,TwS,Hydroxychloroquine + ceftriaxone with Full 30-day follow up
1006,1,1006000011,TwS,Chloroquine with Full 30-day follow up
1007,1,1007000011,TwS,Azithromycin with Full 30-day follow up
1008,1,1008000011,TwS,Fluoroquinolones with Full 30-day follow up
1009,1,1009000011,TwS,Amoxicillin with Full 30-day follow up
1010,1,1010000011,TwS,Ceftriaxone with Full 30-day follow up
1011,1,1011000011,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with Full 30-day follow up"
1012,1,1012000011,TwS,tocilizumab with Full 30-day follow up
1013,1,1013000011,TwS,siltuximab with Full 30-day follow up
1014,1,1014000011,TwS,sarilumab with Full 30-day follow up
1015,1,1015000011,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with Full 30-day follow up"
1016,1,1016000011,TwS,baricitinib with Full 30-day follow up
1017,1,1017000011,TwS,tofacitinib with Full 30-day follow up
1018,1,1018000011,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with Full 30-day follow up"
1019,1,1019000011,TwS,adalimumab with Full 30-day follow up
1020,1,1020000011,TwS,etanercept with Full 30-day follow up
1021,1,1021000011,TwS,infliximab with Full 30-day follow up
1022,1,1022000011,TwS,ustekinumab with Full 30-day follow up
1023,1,1023000011,TwS,Anakinra with Full 30-day follow up
1024,1,1024000011,TwS,HIV Protease inhibitors with Full 30-day follow up
1025,1,1025000011,TwS,ritonavir/lopinavir with Full 30-day follow up
1026,1,1026000011,TwS,Interferon beta 1b with Full 30-day follow up
1027,1,1027000011,TwS,Interferon beta 1a with Full 30-day follow up
1028,1,1028000011,TwS,Interferon beta 1a with Full 30-day follow up
1029,1,1029000011,TwS,favipiravir with Full 30-day follow up
1030,1,1030000011,TwS,Remdesivir with Full 30-day follow up
1031,1,1031000011,TwS,ribavirin with Full 30-day follow up
1032,1,1032000011,TwS,oseltamivir with Full 30-day follow up
1033,1,1033000011,TwS,Ivermectin with Full 30-day follow up
1034,1,1034000011,TwS,itraconazole with Full 30-day follow up
1035,1,1035000011,TwS,warfarin with Full 30-day follow up
1036,1,1036000011,TwS,heparin with Full 30-day follow up
1037,1,1037000011,TwS,enoxaparin with Full 30-day follow up
1038,1,1038000011,TwS,edoxaban with Full 30-day follow up
1039,1,1039000011,TwS,dabigatran with Full 30-day follow up
1040,1,1040000011,TwS,rivaroxaban with Full 30-day follow up
1041,1,1041000011,TwS,acenocoumarol with Full 30-day follow up
1042,1,1042000011,TwS,apixaban with Full 30-day follow up
1043,1,1043000011,TwS,bemiparin with Full 30-day follow up
1044,1,1044000011,TwS,clopidogrel with Full 30-day follow up
1045,1,1045000011,TwS,aspirin with Full 30-day follow up
1046,1,1046000011,TwS,prasugrel with Full 30-day follow up
1047,1,1047000011,TwS,alteplase with Full 30-day follow up
1048,1,1048000011,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with Full 30-day follow up"
1049,1,1049000011,TwS,tranexamic acid with Full 30-day follow up
1050,1,1050000011,TwS,Ruxolitinib with Full 30-day follow up
1051,1,1051000011,TwS,Siltuximab with Full 30-day follow up
1052,1,1052000011,TwS,ACE inhibitors with Full 30-day follow up
1053,1,1053000011,TwS,Angiotensin receptor blockers (ARBs) with Full 30-day follow up
1054,1,1054000011,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with Full 30-day follow up
1055,1,1055000011,TwS,Thiazide or thiazide-like diuretics with Full 30-day follow up
1056,1,1056000011,TwS,Hydrocortisone with Full 30-day follow up
1057,1,1057000011,TwS,dexamethasone with Full 30-day follow up
1058,1,1058000011,TwS,prednisone or prednisolone with Full 30-day follow up
1059,1,1059000011,TwS,raloxifene with Full 30-day follow up
1060,1,1060000011,TwS,Bevacizumab with Full 30-day follow up
1061,1,1061000011,TwS,Fingolimod with Full 30-day follow up
1062,1,1062000011,TwS,eculizumab  with Full 30-day follow up
1063,1,1063000011,TwS,Statins with Full 30-day follow up
1064,1,1064000011,TwS,metformin with Full 30-day follow up
1065,1,1065000011,TwS,DPP-4 inhibitors with Full 30-day follow up
1066,1,1066000011,TwS,SGLT2 inhibitors with Full 30-day follow up
1067,1,1067000011,TwS,GLP1 inhibitors with Full 30-day follow up
1068,1,1068000011,TwS,H2 receptor antagonist with Full 30-day follow up
1069,1,1069000011,TwS,famotidine with Full 30-day follow up
1070,1,1070000011,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with Full 30-day follow up"
1071,1,1071000011,TwS,prazosin with Full 30-day follow up
1072,1,1072000011,TwS,terazosin with Full 30-day follow up
1073,1,1073000011,TwS,doxazosin with Full 30-day follow up
1074,1,1074000011,TwS,tamsulosin with Full 30-day follow up
1075,1,1075000011,TwS,BCG vaccine with Full 30-day follow up
1076,1,1076000011,TwS,Colchicine with Full 30-day follow up
1077,1,1077000011,TwS,Losartan with Full 30-day follow up
1078,1,1078000011,TwS,cholecalciferol with Full 30-day follow up
1079,1,1079000011,TwS,Ibrutinib with Full 30-day follow up
1080,1,1080000011,TwS,abiraterone with Full 30-day follow up
1081,1,1081000011,TwS,bicalutamide with Full 30-day follow up
1082,1,1082000011,TwS,emtricitabine with Full 30-day follow up
1083,1,1083000011,TwS,tacrolimus with Full 30-day follow up
1001,2,1001000021,TwS,Hydroxychloroquine  with < 30-day follow up
1002,2,1002000021,TwS,Hydroxychloroquine + Azithromycin  with < 30-day follow up
1003,2,1003000021,TwS,Hydroxychloroquine + Fluoroquinolones with < 30-day follow up
1004,2,1004000021,TwS,Hydroxychloroquine + Amoxicillin with < 30-day follow up
1005,2,1005000021,TwS,Hydroxychloroquine + ceftriaxone with < 30-day follow up
1006,2,1006000021,TwS,Chloroquine with < 30-day follow up
1007,2,1007000021,TwS,Azithromycin with < 30-day follow up
1008,2,1008000021,TwS,Fluoroquinolones with < 30-day follow up
1009,2,1009000021,TwS,Amoxicillin with < 30-day follow up
1010,2,1010000021,TwS,Ceftriaxone with < 30-day follow up
1011,2,1011000021,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with < 30-day follow up"
1012,2,1012000021,TwS,tocilizumab with < 30-day follow up
1013,2,1013000021,TwS,siltuximab with < 30-day follow up
1014,2,1014000021,TwS,sarilumab with < 30-day follow up
1015,2,1015000021,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with < 30-day follow up"
1016,2,1016000021,TwS,baricitinib with < 30-day follow up
1017,2,1017000021,TwS,tofacitinib with < 30-day follow up
1018,2,1018000021,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with < 30-day follow up"
1019,2,1019000021,TwS,adalimumab with < 30-day follow up
1020,2,1020000021,TwS,etanercept with < 30-day follow up
1021,2,1021000021,TwS,infliximab with < 30-day follow up
1022,2,1022000021,TwS,ustekinumab with < 30-day follow up
1023,2,1023000021,TwS,Anakinra with < 30-day follow up
1024,2,1024000021,TwS,HIV Protease inhibitors with < 30-day follow up
1025,2,1025000021,TwS,ritonavir/lopinavir with < 30-day follow up
1026,2,1026000021,TwS,Interferon beta 1b with < 30-day follow up
1027,2,1027000021,TwS,Interferon beta 1a with < 30-day follow up
1028,2,1028000021,TwS,Interferon beta 1a with < 30-day follow up
1029,2,1029000021,TwS,favipiravir with < 30-day follow up
1030,2,1030000021,TwS,Remdesivir with < 30-day follow up
1031,2,1031000021,TwS,ribavirin with < 30-day follow up
1032,2,1032000021,TwS,oseltamivir with < 30-day follow up
1033,2,1033000021,TwS,Ivermectin with < 30-day follow up
1034,2,1034000021,TwS,itraconazole with < 30-day follow up
1035,2,1035000021,TwS,warfarin with < 30-day follow up
1036,2,1036000021,TwS,heparin with < 30-day follow up
1037,2,1037000021,TwS,enoxaparin with < 30-day follow up
1038,2,1038000021,TwS,edoxaban with < 30-day follow up
1039,2,1039000021,TwS,dabigatran with < 30-day follow up
1040,2,1040000021,TwS,rivaroxaban with < 30-day follow up
1041,2,1041000021,TwS,acenocoumarol with < 30-day follow up
1042,2,1042000021,TwS,apixaban with < 30-day follow up
1043,2,1043000021,TwS,bemiparin with < 30-day follow up
1044,2,1044000021,TwS,clopidogrel with < 30-day follow up
1045,2,1045000021,TwS,aspirin with < 30-day follow up
1046,2,1046000021,TwS,prasugrel with < 30-day follow up
1047,2,1047000021,TwS,alteplase with < 30-day follow up
1048,2,1048000021,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with < 30-day follow up"
1049,2,1049000021,TwS,tranexamic acid with < 30-day follow up
1050,2,1050000021,TwS,Ruxolitinib with < 30-day follow up
1051,2,1051000021,TwS,Siltuximab with < 30-day follow up
1052,2,1052000021,TwS,ACE inhibitors with < 30-day follow up
1053,2,1053000021,TwS,Angiotensin receptor blockers (ARBs) with < 30-day follow up
1054,2,1054000021,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with < 30-day follow up
1055,2,1055000021,TwS,Thiazide or thiazide-like diuretics with < 30-day follow up
1056,2,1056000021,TwS,Hydrocortisone with < 30-day follow up
1057,2,1057000021,TwS,dexamethasone with < 30-day follow up
1058,2,1058000021,TwS,prednisone or prednisolone with < 30-day follow up
1059,2,1059000021,TwS,raloxifene with < 30-day follow up
1060,2,1060000021,TwS,Bevacizumab with < 30-day follow up
1061,2,1061000021,TwS,Fingolimod with < 30-day follow up
1062,2,1062000021,TwS,eculizumab  with < 30-day follow up
1063,2,1063000021,TwS,Statins with < 30-day follow up
1064,2,1064000021,TwS,metformin with < 30-day follow up
1065,2,1065000021,TwS,DPP-4 inhibitors with < 30-day follow up
1066,2,1066000021,TwS,SGLT2 inhibitors with < 30-day follow up
1067,2,1067000021,TwS,GLP1 inhibitors with < 30-day follow up
1068,2,1068000021,TwS,H2 receptor antagonist with < 30-day follow up
1069,2,1069000021,TwS,famotidine with < 30-day follow up
1070,2,1070000021,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with < 30-day follow up"
1071,2,1071000021,TwS,prazosin with < 30-day follow up
1072,2,1072000021,TwS,terazosin with < 30-day follow up
1073,2,1073000021,TwS,doxazosin with < 30-day follow up
1074,2,1074000021,TwS,tamsulosin with < 30-day follow up
1075,2,1075000021,TwS,BCG vaccine with < 30-day follow up
1076,2,1076000021,TwS,Colchicine with < 30-day follow up
1077,2,1077000021,TwS,Losartan with < 30-day follow up
1078,2,1078000021,TwS,cholecalciferol with < 30-day follow up
1079,2,1079000021,TwS,Ibrutinib with < 30-day follow up
1080,2,1080000021,TwS,abiraterone with < 30-day follow up
1081,2,1081000021,TwS,bicalutamide with < 30-day follow up
1082,2,1082000021,TwS,emtricitabine with < 30-day follow up
1083,2,1083000021,TwS,tacrolimus with < 30-day follow up
1001,3,1001000031,TwS,Hydroxychloroquine  with Sex = Female
1002,3,1002000031,TwS,Hydroxychloroquine + Azithromycin  with Sex = Female
1003,3,1003000031,TwS,Hydroxychloroquine + Fluoroquinolones with Sex = Female
1004,3,1004000031,TwS,Hydroxychloroquine + Amoxicillin with Sex = Female
1005,3,1005000031,TwS,Hydroxychloroquine + ceftriaxone with Sex = Female
1006,3,1006000031,TwS,Chloroquine with Sex = Female
1007,3,1007000031,TwS,Azithromycin with Sex = Female
1008,3,1008000031,TwS,Fluoroquinolones with Sex = Female
1009,3,1009000031,TwS,Amoxicillin with Sex = Female
1010,3,1010000031,TwS,Ceftriaxone with Sex = Female
1011,3,1011000031,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with Sex = Female"
1012,3,1012000031,TwS,tocilizumab with Sex = Female
1013,3,1013000031,TwS,siltuximab with Sex = Female
1014,3,1014000031,TwS,sarilumab with Sex = Female
1015,3,1015000031,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with Sex = Female"
1016,3,1016000031,TwS,baricitinib with Sex = Female
1017,3,1017000031,TwS,tofacitinib with Sex = Female
1018,3,1018000031,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with Sex = Female"
1019,3,1019000031,TwS,adalimumab with Sex = Female
1020,3,1020000031,TwS,etanercept with Sex = Female
1021,3,1021000031,TwS,infliximab with Sex = Female
1022,3,1022000031,TwS,ustekinumab with Sex = Female
1023,3,1023000031,TwS,Anakinra with Sex = Female
1024,3,1024000031,TwS,HIV Protease inhibitors with Sex = Female
1025,3,1025000031,TwS,ritonavir/lopinavir with Sex = Female
1026,3,1026000031,TwS,Interferon beta 1b with Sex = Female
1027,3,1027000031,TwS,Interferon beta 1a with Sex = Female
1028,3,1028000031,TwS,Interferon beta 1a with Sex = Female
1029,3,1029000031,TwS,favipiravir with Sex = Female
1030,3,1030000031,TwS,Remdesivir with Sex = Female
1031,3,1031000031,TwS,ribavirin with Sex = Female
1032,3,1032000031,TwS,oseltamivir with Sex = Female
1033,3,1033000031,TwS,Ivermectin with Sex = Female
1034,3,1034000031,TwS,itraconazole with Sex = Female
1035,3,1035000031,TwS,warfarin with Sex = Female
1036,3,1036000031,TwS,heparin with Sex = Female
1037,3,1037000031,TwS,enoxaparin with Sex = Female
1038,3,1038000031,TwS,edoxaban with Sex = Female
1039,3,1039000031,TwS,dabigatran with Sex = Female
1040,3,1040000031,TwS,rivaroxaban with Sex = Female
1041,3,1041000031,TwS,acenocoumarol with Sex = Female
1042,3,1042000031,TwS,apixaban with Sex = Female
1043,3,1043000031,TwS,bemiparin with Sex = Female
1044,3,1044000031,TwS,clopidogrel with Sex = Female
1045,3,1045000031,TwS,aspirin with Sex = Female
1046,3,1046000031,TwS,prasugrel with Sex = Female
1047,3,1047000031,TwS,alteplase with Sex = Female
1048,3,1048000031,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with Sex = Female"
1049,3,1049000031,TwS,tranexamic acid with Sex = Female
1050,3,1050000031,TwS,Ruxolitinib with Sex = Female
1051,3,1051000031,TwS,Siltuximab with Sex = Female
1052,3,1052000031,TwS,ACE inhibitors with Sex = Female
1053,3,1053000031,TwS,Angiotensin receptor blockers (ARBs) with Sex = Female
1054,3,1054000031,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with Sex = Female
1055,3,1055000031,TwS,Thiazide or thiazide-like diuretics with Sex = Female
1056,3,1056000031,TwS,Hydrocortisone with Sex = Female
1057,3,1057000031,TwS,dexamethasone with Sex = Female
1058,3,1058000031,TwS,prednisone or prednisolone with Sex = Female
1059,3,1059000031,TwS,raloxifene with Sex = Female
1060,3,1060000031,TwS,Bevacizumab with Sex = Female
1061,3,1061000031,TwS,Fingolimod with Sex = Female
1062,3,1062000031,TwS,eculizumab  with Sex = Female
1063,3,1063000031,TwS,Statins with Sex = Female
1064,3,1064000031,TwS,metformin with Sex = Female
1065,3,1065000031,TwS,DPP-4 inhibitors with Sex = Female
1066,3,1066000031,TwS,SGLT2 inhibitors with Sex = Female
1067,3,1067000031,TwS,GLP1 inhibitors with Sex = Female
1068,3,1068000031,TwS,H2 receptor antagonist with Sex = Female
1069,3,1069000031,TwS,famotidine with Sex = Female
1070,3,1070000031,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with Sex = Female"
1071,3,1071000031,TwS,prazosin with Sex = Female
1072,3,1072000031,TwS,terazosin with Sex = Female
1073,3,1073000031,TwS,doxazosin with Sex = Female
1074,3,1074000031,TwS,tamsulosin with Sex = Female
1075,3,1075000031,TwS,BCG vaccine with Sex = Female
1076,3,1076000031,TwS,Colchicine with Sex = Female
1077,3,1077000031,TwS,Losartan with Sex = Female
1078,3,1078000031,TwS,cholecalciferol with Sex = Female
1079,3,1079000031,TwS,Ibrutinib with Sex = Female
1080,3,1080000031,TwS,abiraterone with Sex = Female
1081,3,1081000031,TwS,bicalutamide with Sex = Female
1082,3,1082000031,TwS,emtricitabine with Sex = Female
1083,3,1083000031,TwS,tacrolimus with Sex = Female
1001,4,1001000041,TwS,Hydroxychloroquine  with Sex = Male
1002,4,1002000041,TwS,Hydroxychloroquine + Azithromycin  with Sex = Male
1003,4,1003000041,TwS,Hydroxychloroquine + Fluoroquinolones with Sex = Male
1004,4,1004000041,TwS,Hydroxychloroquine + Amoxicillin with Sex = Male
1005,4,1005000041,TwS,Hydroxychloroquine + ceftriaxone with Sex = Male
1006,4,1006000041,TwS,Chloroquine with Sex = Male
1007,4,1007000041,TwS,Azithromycin with Sex = Male
1008,4,1008000041,TwS,Fluoroquinolones with Sex = Male
1009,4,1009000041,TwS,Amoxicillin with Sex = Male
1010,4,1010000041,TwS,Ceftriaxone with Sex = Male
1011,4,1011000041,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with Sex = Male"
1012,4,1012000041,TwS,tocilizumab with Sex = Male
1013,4,1013000041,TwS,siltuximab with Sex = Male
1014,4,1014000041,TwS,sarilumab with Sex = Male
1015,4,1015000041,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with Sex = Male"
1016,4,1016000041,TwS,baricitinib with Sex = Male
1017,4,1017000041,TwS,tofacitinib with Sex = Male
1018,4,1018000041,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with Sex = Male"
1019,4,1019000041,TwS,adalimumab with Sex = Male
1020,4,1020000041,TwS,etanercept with Sex = Male
1021,4,1021000041,TwS,infliximab with Sex = Male
1022,4,1022000041,TwS,ustekinumab with Sex = Male
1023,4,1023000041,TwS,Anakinra with Sex = Male
1024,4,1024000041,TwS,HIV Protease inhibitors with Sex = Male
1025,4,1025000041,TwS,ritonavir/lopinavir with Sex = Male
1026,4,1026000041,TwS,Interferon beta 1b with Sex = Male
1027,4,1027000041,TwS,Interferon beta 1a with Sex = Male
1028,4,1028000041,TwS,Interferon beta 1a with Sex = Male
1029,4,1029000041,TwS,favipiravir with Sex = Male
1030,4,1030000041,TwS,Remdesivir with Sex = Male
1031,4,1031000041,TwS,ribavirin with Sex = Male
1032,4,1032000041,TwS,oseltamivir with Sex = Male
1033,4,1033000041,TwS,Ivermectin with Sex = Male
1034,4,1034000041,TwS,itraconazole with Sex = Male
1035,4,1035000041,TwS,warfarin with Sex = Male
1036,4,1036000041,TwS,heparin with Sex = Male
1037,4,1037000041,TwS,enoxaparin with Sex = Male
1038,4,1038000041,TwS,edoxaban with Sex = Male
1039,4,1039000041,TwS,dabigatran with Sex = Male
1040,4,1040000041,TwS,rivaroxaban with Sex = Male
1041,4,1041000041,TwS,acenocoumarol with Sex = Male
1042,4,1042000041,TwS,apixaban with Sex = Male
1043,4,1043000041,TwS,bemiparin with Sex = Male
1044,4,1044000041,TwS,clopidogrel with Sex = Male
1045,4,1045000041,TwS,aspirin with Sex = Male
1046,4,1046000041,TwS,prasugrel with Sex = Male
1047,4,1047000041,TwS,alteplase with Sex = Male
1048,4,1048000041,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with Sex = Male"
1049,4,1049000041,TwS,tranexamic acid with Sex = Male
1050,4,1050000041,TwS,Ruxolitinib with Sex = Male
1051,4,1051000041,TwS,Siltuximab with Sex = Male
1052,4,1052000041,TwS,ACE inhibitors with Sex = Male
1053,4,1053000041,TwS,Angiotensin receptor blockers (ARBs) with Sex = Male
1054,4,1054000041,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with Sex = Male
1055,4,1055000041,TwS,Thiazide or thiazide-like diuretics with Sex = Male
1056,4,1056000041,TwS,Hydrocortisone with Sex = Male
1057,4,1057000041,TwS,dexamethasone with Sex = Male
1058,4,1058000041,TwS,prednisone or prednisolone with Sex = Male
1059,4,1059000041,TwS,raloxifene with Sex = Male
1060,4,1060000041,TwS,Bevacizumab with Sex = Male
1061,4,1061000041,TwS,Fingolimod with Sex = Male
1062,4,1062000041,TwS,eculizumab  with Sex = Male
1063,4,1063000041,TwS,Statins with Sex = Male
1064,4,1064000041,TwS,metformin with Sex = Male
1065,4,1065000041,TwS,DPP-4 inhibitors with Sex = Male
1066,4,1066000041,TwS,SGLT2 inhibitors with Sex = Male
1067,4,1067000041,TwS,GLP1 inhibitors with Sex = Male
1068,4,1068000041,TwS,H2 receptor antagonist with Sex = Male
1069,4,1069000041,TwS,famotidine with Sex = Male
1070,4,1070000041,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with Sex = Male"
1071,4,1071000041,TwS,prazosin with Sex = Male
1072,4,1072000041,TwS,terazosin with Sex = Male
1073,4,1073000041,TwS,doxazosin with Sex = Male
1074,4,1074000041,TwS,tamsulosin with Sex = Male
1075,4,1075000041,TwS,BCG vaccine with Sex = Male
1076,4,1076000041,TwS,Colchicine with Sex = Male
1077,4,1077000041,TwS,Losartan with Sex = Male
1078,4,1078000041,TwS,cholecalciferol with Sex = Male
1079,4,1079000041,TwS,Ibrutinib with Sex = Male
1080,4,1080000041,TwS,abiraterone with Sex = Male
1081,4,1081000041,TwS,bicalutamide with Sex = Male
1082,4,1082000041,TwS,emtricitabine with Sex = Male
1083,4,1083000041,TwS,tacrolimus with Sex = Male
1001,5,1001000051,TwS,Hydroxychloroquine  with Age >= 18
1002,5,1002000051,TwS,Hydroxychloroquine + Azithromycin  with Age >= 18
1003,5,1003000051,TwS,Hydroxychloroquine + Fluoroquinolones with Age >= 18
1004,5,1004000051,TwS,Hydroxychloroquine + Amoxicillin with Age >= 18
1005,5,1005000051,TwS,Hydroxychloroquine + ceftriaxone with Age >= 18
1006,5,1006000051,TwS,Chloroquine with Age >= 18
1007,5,1007000051,TwS,Azithromycin with Age >= 18
1008,5,1008000051,TwS,Fluoroquinolones with Age >= 18
1009,5,1009000051,TwS,Amoxicillin with Age >= 18
1010,5,1010000051,TwS,Ceftriaxone with Age >= 18
1011,5,1011000051,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with Age >= 18"
1012,5,1012000051,TwS,tocilizumab with Age >= 18
1013,5,1013000051,TwS,siltuximab with Age >= 18
1014,5,1014000051,TwS,sarilumab with Age >= 18
1015,5,1015000051,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with Age >= 18"
1016,5,1016000051,TwS,baricitinib with Age >= 18
1017,5,1017000051,TwS,tofacitinib with Age >= 18
1018,5,1018000051,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with Age >= 18"
1019,5,1019000051,TwS,adalimumab with Age >= 18
1020,5,1020000051,TwS,etanercept with Age >= 18
1021,5,1021000051,TwS,infliximab with Age >= 18
1022,5,1022000051,TwS,ustekinumab with Age >= 18
1023,5,1023000051,TwS,Anakinra with Age >= 18
1024,5,1024000051,TwS,HIV Protease inhibitors with Age >= 18
1025,5,1025000051,TwS,ritonavir/lopinavir with Age >= 18
1026,5,1026000051,TwS,Interferon beta 1b with Age >= 18
1027,5,1027000051,TwS,Interferon beta 1a with Age >= 18
1028,5,1028000051,TwS,Interferon beta 1a with Age >= 18
1029,5,1029000051,TwS,favipiravir with Age >= 18
1030,5,1030000051,TwS,Remdesivir with Age >= 18
1031,5,1031000051,TwS,ribavirin with Age >= 18
1032,5,1032000051,TwS,oseltamivir with Age >= 18
1033,5,1033000051,TwS,Ivermectin with Age >= 18
1034,5,1034000051,TwS,itraconazole with Age >= 18
1035,5,1035000051,TwS,warfarin with Age >= 18
1036,5,1036000051,TwS,heparin with Age >= 18
1037,5,1037000051,TwS,enoxaparin with Age >= 18
1038,5,1038000051,TwS,edoxaban with Age >= 18
1039,5,1039000051,TwS,dabigatran with Age >= 18
1040,5,1040000051,TwS,rivaroxaban with Age >= 18
1041,5,1041000051,TwS,acenocoumarol with Age >= 18
1042,5,1042000051,TwS,apixaban with Age >= 18
1043,5,1043000051,TwS,bemiparin with Age >= 18
1044,5,1044000051,TwS,clopidogrel with Age >= 18
1045,5,1045000051,TwS,aspirin with Age >= 18
1046,5,1046000051,TwS,prasugrel with Age >= 18
1047,5,1047000051,TwS,alteplase with Age >= 18
1048,5,1048000051,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with Age >= 18"
1049,5,1049000051,TwS,tranexamic acid with Age >= 18
1050,5,1050000051,TwS,Ruxolitinib with Age >= 18
1051,5,1051000051,TwS,Siltuximab with Age >= 18
1052,5,1052000051,TwS,ACE inhibitors with Age >= 18
1053,5,1053000051,TwS,Angiotensin receptor blockers (ARBs) with Age >= 18
1054,5,1054000051,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with Age >= 18
1055,5,1055000051,TwS,Thiazide or thiazide-like diuretics with Age >= 18
1056,5,1056000051,TwS,Hydrocortisone with Age >= 18
1057,5,1057000051,TwS,dexamethasone with Age >= 18
1058,5,1058000051,TwS,prednisone or prednisolone with Age >= 18
1059,5,1059000051,TwS,raloxifene with Age >= 18
1060,5,1060000051,TwS,Bevacizumab with Age >= 18
1061,5,1061000051,TwS,Fingolimod with Age >= 18
1062,5,1062000051,TwS,eculizumab  with Age >= 18
1063,5,1063000051,TwS,Statins with Age >= 18
1064,5,1064000051,TwS,metformin with Age >= 18
1065,5,1065000051,TwS,DPP-4 inhibitors with Age >= 18
1066,5,1066000051,TwS,SGLT2 inhibitors with Age >= 18
1067,5,1067000051,TwS,GLP1 inhibitors with Age >= 18
1068,5,1068000051,TwS,H2 receptor antagonist with Age >= 18
1069,5,1069000051,TwS,famotidine with Age >= 18
1070,5,1070000051,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with Age >= 18"
1071,5,1071000051,TwS,prazosin with Age >= 18
1072,5,1072000051,TwS,terazosin with Age >= 18
1073,5,1073000051,TwS,doxazosin with Age >= 18
1074,5,1074000051,TwS,tamsulosin with Age >= 18
1075,5,1075000051,TwS,BCG vaccine with Age >= 18
1076,5,1076000051,TwS,Colchicine with Age >= 18
1077,5,1077000051,TwS,Losartan with Age >= 18
1078,5,1078000051,TwS,cholecalciferol with Age >= 18
1079,5,1079000051,TwS,Ibrutinib with Age >= 18
1080,5,1080000051,TwS,abiraterone with Age >= 18
1081,5,1081000051,TwS,bicalutamide with Age >= 18
1082,5,1082000051,TwS,emtricitabine with Age >= 18
1083,5,1083000051,TwS,tacrolimus with Age >= 18
1001,6,1001000061,TwS,Hydroxychloroquine  with Age < 18
1002,6,1002000061,TwS,Hydroxychloroquine + Azithromycin  with Age < 18
1003,6,1003000061,TwS,Hydroxychloroquine + Fluoroquinolones with Age < 18
1004,6,1004000061,TwS,Hydroxychloroquine + Amoxicillin with Age < 18
1005,6,1005000061,TwS,Hydroxychloroquine + ceftriaxone with Age < 18
1006,6,1006000061,TwS,Chloroquine with Age < 18
1007,6,1007000061,TwS,Azithromycin with Age < 18
1008,6,1008000061,TwS,Fluoroquinolones with Age < 18
1009,6,1009000061,TwS,Amoxicillin with Age < 18
1010,6,1010000061,TwS,Ceftriaxone with Age < 18
1011,6,1011000061,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with Age < 18"
1012,6,1012000061,TwS,tocilizumab with Age < 18
1013,6,1013000061,TwS,siltuximab with Age < 18
1014,6,1014000061,TwS,sarilumab with Age < 18
1015,6,1015000061,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with Age < 18"
1016,6,1016000061,TwS,baricitinib with Age < 18
1017,6,1017000061,TwS,tofacitinib with Age < 18
1018,6,1018000061,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with Age < 18"
1019,6,1019000061,TwS,adalimumab with Age < 18
1020,6,1020000061,TwS,etanercept with Age < 18
1021,6,1021000061,TwS,infliximab with Age < 18
1022,6,1022000061,TwS,ustekinumab with Age < 18
1023,6,1023000061,TwS,Anakinra with Age < 18
1024,6,1024000061,TwS,HIV Protease inhibitors with Age < 18
1025,6,1025000061,TwS,ritonavir/lopinavir with Age < 18
1026,6,1026000061,TwS,Interferon beta 1b with Age < 18
1027,6,1027000061,TwS,Interferon beta 1a with Age < 18
1028,6,1028000061,TwS,Interferon beta 1a with Age < 18
1029,6,1029000061,TwS,favipiravir with Age < 18
1030,6,1030000061,TwS,Remdesivir with Age < 18
1031,6,1031000061,TwS,ribavirin with Age < 18
1032,6,1032000061,TwS,oseltamivir with Age < 18
1033,6,1033000061,TwS,Ivermectin with Age < 18
1034,6,1034000061,TwS,itraconazole with Age < 18
1035,6,1035000061,TwS,warfarin with Age < 18
1036,6,1036000061,TwS,heparin with Age < 18
1037,6,1037000061,TwS,enoxaparin with Age < 18
1038,6,1038000061,TwS,edoxaban with Age < 18
1039,6,1039000061,TwS,dabigatran with Age < 18
1040,6,1040000061,TwS,rivaroxaban with Age < 18
1041,6,1041000061,TwS,acenocoumarol with Age < 18
1042,6,1042000061,TwS,apixaban with Age < 18
1043,6,1043000061,TwS,bemiparin with Age < 18
1044,6,1044000061,TwS,clopidogrel with Age < 18
1045,6,1045000061,TwS,aspirin with Age < 18
1046,6,1046000061,TwS,prasugrel with Age < 18
1047,6,1047000061,TwS,alteplase with Age < 18
1048,6,1048000061,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with Age < 18"
1049,6,1049000061,TwS,tranexamic acid with Age < 18
1050,6,1050000061,TwS,Ruxolitinib with Age < 18
1051,6,1051000061,TwS,Siltuximab with Age < 18
1052,6,1052000061,TwS,ACE inhibitors with Age < 18
1053,6,1053000061,TwS,Angiotensin receptor blockers (ARBs) with Age < 18
1054,6,1054000061,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with Age < 18
1055,6,1055000061,TwS,Thiazide or thiazide-like diuretics with Age < 18
1056,6,1056000061,TwS,Hydrocortisone with Age < 18
1057,6,1057000061,TwS,dexamethasone with Age < 18
1058,6,1058000061,TwS,prednisone or prednisolone with Age < 18
1059,6,1059000061,TwS,raloxifene with Age < 18
1060,6,1060000061,TwS,Bevacizumab with Age < 18
1061,6,1061000061,TwS,Fingolimod with Age < 18
1062,6,1062000061,TwS,eculizumab  with Age < 18
1063,6,1063000061,TwS,Statins with Age < 18
1064,6,1064000061,TwS,metformin with Age < 18
1065,6,1065000061,TwS,DPP-4 inhibitors with Age < 18
1066,6,1066000061,TwS,SGLT2 inhibitors with Age < 18
1067,6,1067000061,TwS,GLP1 inhibitors with Age < 18
1068,6,1068000061,TwS,H2 receptor antagonist with Age < 18
1069,6,1069000061,TwS,famotidine with Age < 18
1070,6,1070000061,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with Age < 18"
1071,6,1071000061,TwS,prazosin with Age < 18
1072,6,1072000061,TwS,terazosin with Age < 18
1073,6,1073000061,TwS,doxazosin with Age < 18
1074,6,1074000061,TwS,tamsulosin with Age < 18
1075,6,1075000061,TwS,BCG vaccine with Age < 18
1076,6,1076000061,TwS,Colchicine with Age < 18
1077,6,1077000061,TwS,Losartan with Age < 18
1078,6,1078000061,TwS,cholecalciferol with Age < 18
1079,6,1079000061,TwS,Ibrutinib with Age < 18
1080,6,1080000061,TwS,abiraterone with Age < 18
1081,6,1081000061,TwS,bicalutamide with Age < 18
1082,6,1082000061,TwS,emtricitabine with Age < 18
1083,6,1083000061,TwS,tacrolimus with Age < 18
1001,7,1001000071,TwS,Hydroxychloroquine  with Age >= 65
1002,7,1002000071,TwS,Hydroxychloroquine + Azithromycin  with Age >= 65
1003,7,1003000071,TwS,Hydroxychloroquine + Fluoroquinolones with Age >= 65
1004,7,1004000071,TwS,Hydroxychloroquine + Amoxicillin with Age >= 65
1005,7,1005000071,TwS,Hydroxychloroquine + ceftriaxone with Age >= 65
1006,7,1006000071,TwS,Chloroquine with Age >= 65
1007,7,1007000071,TwS,Azithromycin with Age >= 65
1008,7,1008000071,TwS,Fluoroquinolones with Age >= 65
1009,7,1009000071,TwS,Amoxicillin with Age >= 65
1010,7,1010000071,TwS,Ceftriaxone with Age >= 65
1011,7,1011000071,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with Age >= 65"
1012,7,1012000071,TwS,tocilizumab with Age >= 65
1013,7,1013000071,TwS,siltuximab with Age >= 65
1014,7,1014000071,TwS,sarilumab with Age >= 65
1015,7,1015000071,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with Age >= 65"
1016,7,1016000071,TwS,baricitinib with Age >= 65
1017,7,1017000071,TwS,tofacitinib with Age >= 65
1018,7,1018000071,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with Age >= 65"
1019,7,1019000071,TwS,adalimumab with Age >= 65
1020,7,1020000071,TwS,etanercept with Age >= 65
1021,7,1021000071,TwS,infliximab with Age >= 65
1022,7,1022000071,TwS,ustekinumab with Age >= 65
1023,7,1023000071,TwS,Anakinra with Age >= 65
1024,7,1024000071,TwS,HIV Protease inhibitors with Age >= 65
1025,7,1025000071,TwS,ritonavir/lopinavir with Age >= 65
1026,7,1026000071,TwS,Interferon beta 1b with Age >= 65
1027,7,1027000071,TwS,Interferon beta 1a with Age >= 65
1028,7,1028000071,TwS,Interferon beta 1a with Age >= 65
1029,7,1029000071,TwS,favipiravir with Age >= 65
1030,7,1030000071,TwS,Remdesivir with Age >= 65
1031,7,1031000071,TwS,ribavirin with Age >= 65
1032,7,1032000071,TwS,oseltamivir with Age >= 65
1033,7,1033000071,TwS,Ivermectin with Age >= 65
1034,7,1034000071,TwS,itraconazole with Age >= 65
1035,7,1035000071,TwS,warfarin with Age >= 65
1036,7,1036000071,TwS,heparin with Age >= 65
1037,7,1037000071,TwS,enoxaparin with Age >= 65
1038,7,1038000071,TwS,edoxaban with Age >= 65
1039,7,1039000071,TwS,dabigatran with Age >= 65
1040,7,1040000071,TwS,rivaroxaban with Age >= 65
1041,7,1041000071,TwS,acenocoumarol with Age >= 65
1042,7,1042000071,TwS,apixaban with Age >= 65
1043,7,1043000071,TwS,bemiparin with Age >= 65
1044,7,1044000071,TwS,clopidogrel with Age >= 65
1045,7,1045000071,TwS,aspirin with Age >= 65
1046,7,1046000071,TwS,prasugrel with Age >= 65
1047,7,1047000071,TwS,alteplase with Age >= 65
1048,7,1048000071,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with Age >= 65"
1049,7,1049000071,TwS,tranexamic acid with Age >= 65
1050,7,1050000071,TwS,Ruxolitinib with Age >= 65
1051,7,1051000071,TwS,Siltuximab with Age >= 65
1052,7,1052000071,TwS,ACE inhibitors with Age >= 65
1053,7,1053000071,TwS,Angiotensin receptor blockers (ARBs) with Age >= 65
1054,7,1054000071,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with Age >= 65
1055,7,1055000071,TwS,Thiazide or thiazide-like diuretics with Age >= 65
1056,7,1056000071,TwS,Hydrocortisone with Age >= 65
1057,7,1057000071,TwS,dexamethasone with Age >= 65
1058,7,1058000071,TwS,prednisone or prednisolone with Age >= 65
1059,7,1059000071,TwS,raloxifene with Age >= 65
1060,7,1060000071,TwS,Bevacizumab with Age >= 65
1061,7,1061000071,TwS,Fingolimod with Age >= 65
1062,7,1062000071,TwS,eculizumab  with Age >= 65
1063,7,1063000071,TwS,Statins with Age >= 65
1064,7,1064000071,TwS,metformin with Age >= 65
1065,7,1065000071,TwS,DPP-4 inhibitors with Age >= 65
1066,7,1066000071,TwS,SGLT2 inhibitors with Age >= 65
1067,7,1067000071,TwS,GLP1 inhibitors with Age >= 65
1068,7,1068000071,TwS,H2 receptor antagonist with Age >= 65
1069,7,1069000071,TwS,famotidine with Age >= 65
1070,7,1070000071,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with Age >= 65"
1071,7,1071000071,TwS,prazosin with Age >= 65
1072,7,1072000071,TwS,terazosin with Age >= 65
1073,7,1073000071,TwS,doxazosin with Age >= 65
1074,7,1074000071,TwS,tamsulosin with Age >= 65
1075,7,1075000071,TwS,BCG vaccine with Age >= 65
1076,7,1076000071,TwS,Colchicine with Age >= 65
1077,7,1077000071,TwS,Losartan with Age >= 65
1078,7,1078000071,TwS,cholecalciferol with Age >= 65
1079,7,1079000071,TwS,Ibrutinib with Age >= 65
1080,7,1080000071,TwS,abiraterone with Age >= 65
1081,7,1081000071,TwS,bicalutamide with Age >= 65
1082,7,1082000071,TwS,emtricitabine with Age >= 65
1083,7,1083000071,TwS,tacrolimus with Age >= 65
1001,8,1001000081,TwS,Hydroxychloroquine  with Age < 65
1002,8,1002000081,TwS,Hydroxychloroquine + Azithromycin  with Age < 65
1003,8,1003000081,TwS,Hydroxychloroquine + Fluoroquinolones with Age < 65
1004,8,1004000081,TwS,Hydroxychloroquine + Amoxicillin with Age < 65
1005,8,1005000081,TwS,Hydroxychloroquine + ceftriaxone with Age < 65
1006,8,1006000081,TwS,Chloroquine with Age < 65
1007,8,1007000081,TwS,Azithromycin with Age < 65
1008,8,1008000081,TwS,Fluoroquinolones with Age < 65
1009,8,1009000081,TwS,Amoxicillin with Age < 65
1010,8,1010000081,TwS,Ceftriaxone with Age < 65
1011,8,1011000081,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with Age < 65"
1012,8,1012000081,TwS,tocilizumab with Age < 65
1013,8,1013000081,TwS,siltuximab with Age < 65
1014,8,1014000081,TwS,sarilumab with Age < 65
1015,8,1015000081,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with Age < 65"
1016,8,1016000081,TwS,baricitinib with Age < 65
1017,8,1017000081,TwS,tofacitinib with Age < 65
1018,8,1018000081,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with Age < 65"
1019,8,1019000081,TwS,adalimumab with Age < 65
1020,8,1020000081,TwS,etanercept with Age < 65
1021,8,1021000081,TwS,infliximab with Age < 65
1022,8,1022000081,TwS,ustekinumab with Age < 65
1023,8,1023000081,TwS,Anakinra with Age < 65
1024,8,1024000081,TwS,HIV Protease inhibitors with Age < 65
1025,8,1025000081,TwS,ritonavir/lopinavir with Age < 65
1026,8,1026000081,TwS,Interferon beta 1b with Age < 65
1027,8,1027000081,TwS,Interferon beta 1a with Age < 65
1028,8,1028000081,TwS,Interferon beta 1a with Age < 65
1029,8,1029000081,TwS,favipiravir with Age < 65
1030,8,1030000081,TwS,Remdesivir with Age < 65
1031,8,1031000081,TwS,ribavirin with Age < 65
1032,8,1032000081,TwS,oseltamivir with Age < 65
1033,8,1033000081,TwS,Ivermectin with Age < 65
1034,8,1034000081,TwS,itraconazole with Age < 65
1035,8,1035000081,TwS,warfarin with Age < 65
1036,8,1036000081,TwS,heparin with Age < 65
1037,8,1037000081,TwS,enoxaparin with Age < 65
1038,8,1038000081,TwS,edoxaban with Age < 65
1039,8,1039000081,TwS,dabigatran with Age < 65
1040,8,1040000081,TwS,rivaroxaban with Age < 65
1041,8,1041000081,TwS,acenocoumarol with Age < 65
1042,8,1042000081,TwS,apixaban with Age < 65
1043,8,1043000081,TwS,bemiparin with Age < 65
1044,8,1044000081,TwS,clopidogrel with Age < 65
1045,8,1045000081,TwS,aspirin with Age < 65
1046,8,1046000081,TwS,prasugrel with Age < 65
1047,8,1047000081,TwS,alteplase with Age < 65
1048,8,1048000081,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with Age < 65"
1049,8,1049000081,TwS,tranexamic acid with Age < 65
1050,8,1050000081,TwS,Ruxolitinib with Age < 65
1051,8,1051000081,TwS,Siltuximab with Age < 65
1052,8,1052000081,TwS,ACE inhibitors with Age < 65
1053,8,1053000081,TwS,Angiotensin receptor blockers (ARBs) with Age < 65
1054,8,1054000081,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with Age < 65
1055,8,1055000081,TwS,Thiazide or thiazide-like diuretics with Age < 65
1056,8,1056000081,TwS,Hydrocortisone with Age < 65
1057,8,1057000081,TwS,dexamethasone with Age < 65
1058,8,1058000081,TwS,prednisone or prednisolone with Age < 65
1059,8,1059000081,TwS,raloxifene with Age < 65
1060,8,1060000081,TwS,Bevacizumab with Age < 65
1061,8,1061000081,TwS,Fingolimod with Age < 65
1062,8,1062000081,TwS,eculizumab  with Age < 65
1063,8,1063000081,TwS,Statins with Age < 65
1064,8,1064000081,TwS,metformin with Age < 65
1065,8,1065000081,TwS,DPP-4 inhibitors with Age < 65
1066,8,1066000081,TwS,SGLT2 inhibitors with Age < 65
1067,8,1067000081,TwS,GLP1 inhibitors with Age < 65
1068,8,1068000081,TwS,H2 receptor antagonist with Age < 65
1069,8,1069000081,TwS,famotidine with Age < 65
1070,8,1070000081,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with Age < 65"
1071,8,1071000081,TwS,prazosin with Age < 65
1072,8,1072000081,TwS,terazosin with Age < 65
1073,8,1073000081,TwS,doxazosin with Age < 65
1074,8,1074000081,TwS,tamsulosin with Age < 65
1075,8,1075000081,TwS,BCG vaccine with Age < 65
1076,8,1076000081,TwS,Colchicine with Age < 65
1077,8,1077000081,TwS,Losartan with Age < 65
1078,8,1078000081,TwS,cholecalciferol with Age < 65
1079,8,1079000081,TwS,Ibrutinib with Age < 65
1080,8,1080000081,TwS,abiraterone with Age < 65
1081,8,1081000081,TwS,bicalutamide with Age < 65
1082,8,1082000081,TwS,emtricitabine with Age < 65
1083,8,1083000081,TwS,tacrolimus with Age < 65
1001,9,1001000091,TwS,Hydroxychloroquine  with Black or African American
1002,9,1002000091,TwS,Hydroxychloroquine + Azithromycin  with Black or African American
1003,9,1003000091,TwS,Hydroxychloroquine + Fluoroquinolones with Black or African American
1004,9,1004000091,TwS,Hydroxychloroquine + Amoxicillin with Black or African American
1005,9,1005000091,TwS,Hydroxychloroquine + ceftriaxone with Black or African American
1006,9,1006000091,TwS,Chloroquine with Black or African American
1007,9,1007000091,TwS,Azithromycin with Black or African American
1008,9,1008000091,TwS,Fluoroquinolones with Black or African American
1009,9,1009000091,TwS,Amoxicillin with Black or African American
1010,9,1010000091,TwS,Ceftriaxone with Black or African American
1011,9,1011000091,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with Black or African American"
1012,9,1012000091,TwS,tocilizumab with Black or African American
1013,9,1013000091,TwS,siltuximab with Black or African American
1014,9,1014000091,TwS,sarilumab with Black or African American
1015,9,1015000091,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with Black or African American"
1016,9,1016000091,TwS,baricitinib with Black or African American
1017,9,1017000091,TwS,tofacitinib with Black or African American
1018,9,1018000091,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with Black or African American"
1019,9,1019000091,TwS,adalimumab with Black or African American
1020,9,1020000091,TwS,etanercept with Black or African American
1021,9,1021000091,TwS,infliximab with Black or African American
1022,9,1022000091,TwS,ustekinumab with Black or African American
1023,9,1023000091,TwS,Anakinra with Black or African American
1024,9,1024000091,TwS,HIV Protease inhibitors with Black or African American
1025,9,1025000091,TwS,ritonavir/lopinavir with Black or African American
1026,9,1026000091,TwS,Interferon beta 1b with Black or African American
1027,9,1027000091,TwS,Interferon beta 1a with Black or African American
1028,9,1028000091,TwS,Interferon beta 1a with Black or African American
1029,9,1029000091,TwS,favipiravir with Black or African American
1030,9,1030000091,TwS,Remdesivir with Black or African American
1031,9,1031000091,TwS,ribavirin with Black or African American
1032,9,1032000091,TwS,oseltamivir with Black or African American
1033,9,1033000091,TwS,Ivermectin with Black or African American
1034,9,1034000091,TwS,itraconazole with Black or African American
1035,9,1035000091,TwS,warfarin with Black or African American
1036,9,1036000091,TwS,heparin with Black or African American
1037,9,1037000091,TwS,enoxaparin with Black or African American
1038,9,1038000091,TwS,edoxaban with Black or African American
1039,9,1039000091,TwS,dabigatran with Black or African American
1040,9,1040000091,TwS,rivaroxaban with Black or African American
1041,9,1041000091,TwS,acenocoumarol with Black or African American
1042,9,1042000091,TwS,apixaban with Black or African American
1043,9,1043000091,TwS,bemiparin with Black or African American
1044,9,1044000091,TwS,clopidogrel with Black or African American
1045,9,1045000091,TwS,aspirin with Black or African American
1046,9,1046000091,TwS,prasugrel with Black or African American
1047,9,1047000091,TwS,alteplase with Black or African American
1048,9,1048000091,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with Black or African American"
1049,9,1049000091,TwS,tranexamic acid with Black or African American
1050,9,1050000091,TwS,Ruxolitinib with Black or African American
1051,9,1051000091,TwS,Siltuximab with Black or African American
1052,9,1052000091,TwS,ACE inhibitors with Black or African American
1053,9,1053000091,TwS,Angiotensin receptor blockers (ARBs) with Black or African American
1054,9,1054000091,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with Black or African American
1055,9,1055000091,TwS,Thiazide or thiazide-like diuretics with Black or African American
1056,9,1056000091,TwS,Hydrocortisone with Black or African American
1057,9,1057000091,TwS,dexamethasone with Black or African American
1058,9,1058000091,TwS,prednisone or prednisolone with Black or African American
1059,9,1059000091,TwS,raloxifene with Black or African American
1060,9,1060000091,TwS,Bevacizumab with Black or African American
1061,9,1061000091,TwS,Fingolimod with Black or African American
1062,9,1062000091,TwS,eculizumab  with Black or African American
1063,9,1063000091,TwS,Statins with Black or African American
1064,9,1064000091,TwS,metformin with Black or African American
1065,9,1065000091,TwS,DPP-4 inhibitors with Black or African American
1066,9,1066000091,TwS,SGLT2 inhibitors with Black or African American
1067,9,1067000091,TwS,GLP1 inhibitors with Black or African American
1068,9,1068000091,TwS,H2 receptor antagonist with Black or African American
1069,9,1069000091,TwS,famotidine with Black or African American
1070,9,1070000091,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with Black or African American"
1071,9,1071000091,TwS,prazosin with Black or African American
1072,9,1072000091,TwS,terazosin with Black or African American
1073,9,1073000091,TwS,doxazosin with Black or African American
1074,9,1074000091,TwS,tamsulosin with Black or African American
1075,9,1075000091,TwS,BCG vaccine with Black or African American
1076,9,1076000091,TwS,Colchicine with Black or African American
1077,9,1077000091,TwS,Losartan with Black or African American
1078,9,1078000091,TwS,cholecalciferol with Black or African American
1079,9,1079000091,TwS,Ibrutinib with Black or African American
1080,9,1080000091,TwS,abiraterone with Black or African American
1081,9,1081000091,TwS,bicalutamide with Black or African American
1082,9,1082000091,TwS,emtricitabine with Black or African American
1083,9,1083000091,TwS,tacrolimus with Black or African American
1001,10,1001000101,TwS,Hydroxychloroquine  with White
1002,10,1002000101,TwS,Hydroxychloroquine + Azithromycin  with White
1003,10,1003000101,TwS,Hydroxychloroquine + Fluoroquinolones with White
1004,10,1004000101,TwS,Hydroxychloroquine + Amoxicillin with White
1005,10,1005000101,TwS,Hydroxychloroquine + ceftriaxone with White
1006,10,1006000101,TwS,Chloroquine with White
1007,10,1007000101,TwS,Azithromycin with White
1008,10,1008000101,TwS,Fluoroquinolones with White
1009,10,1009000101,TwS,Amoxicillin with White
1010,10,1010000101,TwS,Ceftriaxone with White
1011,10,1011000101,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with White"
1012,10,1012000101,TwS,tocilizumab with White
1013,10,1013000101,TwS,siltuximab with White
1014,10,1014000101,TwS,sarilumab with White
1015,10,1015000101,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with White"
1016,10,1016000101,TwS,baricitinib with White
1017,10,1017000101,TwS,tofacitinib with White
1018,10,1018000101,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with White"
1019,10,1019000101,TwS,adalimumab with White
1020,10,1020000101,TwS,etanercept with White
1021,10,1021000101,TwS,infliximab with White
1022,10,1022000101,TwS,ustekinumab with White
1023,10,1023000101,TwS,Anakinra with White
1024,10,1024000101,TwS,HIV Protease inhibitors with White
1025,10,1025000101,TwS,ritonavir/lopinavir with White
1026,10,1026000101,TwS,Interferon beta 1b with White
1027,10,1027000101,TwS,Interferon beta 1a with White
1028,10,1028000101,TwS,Interferon beta 1a with White
1029,10,1029000101,TwS,favipiravir with White
1030,10,1030000101,TwS,Remdesivir with White
1031,10,1031000101,TwS,ribavirin with White
1032,10,1032000101,TwS,oseltamivir with White
1033,10,1033000101,TwS,Ivermectin with White
1034,10,1034000101,TwS,itraconazole with White
1035,10,1035000101,TwS,warfarin with White
1036,10,1036000101,TwS,heparin with White
1037,10,1037000101,TwS,enoxaparin with White
1038,10,1038000101,TwS,edoxaban with White
1039,10,1039000101,TwS,dabigatran with White
1040,10,1040000101,TwS,rivaroxaban with White
1041,10,1041000101,TwS,acenocoumarol with White
1042,10,1042000101,TwS,apixaban with White
1043,10,1043000101,TwS,bemiparin with White
1044,10,1044000101,TwS,clopidogrel with White
1045,10,1045000101,TwS,aspirin with White
1046,10,1046000101,TwS,prasugrel with White
1047,10,1047000101,TwS,alteplase with White
1048,10,1048000101,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with White"
1049,10,1049000101,TwS,tranexamic acid with White
1050,10,1050000101,TwS,Ruxolitinib with White
1051,10,1051000101,TwS,Siltuximab with White
1052,10,1052000101,TwS,ACE inhibitors with White
1053,10,1053000101,TwS,Angiotensin receptor blockers (ARBs) with White
1054,10,1054000101,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with White
1055,10,1055000101,TwS,Thiazide or thiazide-like diuretics with White
1056,10,1056000101,TwS,Hydrocortisone with White
1057,10,1057000101,TwS,dexamethasone with White
1058,10,1058000101,TwS,prednisone or prednisolone with White
1059,10,1059000101,TwS,raloxifene with White
1060,10,1060000101,TwS,Bevacizumab with White
1061,10,1061000101,TwS,Fingolimod with White
1062,10,1062000101,TwS,eculizumab  with White
1063,10,1063000101,TwS,Statins with White
1064,10,1064000101,TwS,metformin with White
1065,10,1065000101,TwS,DPP-4 inhibitors with White
1066,10,1066000101,TwS,SGLT2 inhibitors with White
1067,10,1067000101,TwS,GLP1 inhibitors with White
1068,10,1068000101,TwS,H2 receptor antagonist with White
1069,10,1069000101,TwS,famotidine with White
1070,10,1070000101,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with White"
1071,10,1071000101,TwS,prazosin with White
1072,10,1072000101,TwS,terazosin with White
1073,10,1073000101,TwS,doxazosin with White
1074,10,1074000101,TwS,tamsulosin with White
1075,10,1075000101,TwS,BCG vaccine with White
1076,10,1076000101,TwS,Colchicine with White
1077,10,1077000101,TwS,Losartan with White
1078,10,1078000101,TwS,cholecalciferol with White
1079,10,1079000101,TwS,Ibrutinib with White
1080,10,1080000101,TwS,abiraterone with White
1081,10,1081000101,TwS,bicalutamide with White
1082,10,1082000101,TwS,emtricitabine with White
1083,10,1083000101,TwS,tacrolimus with White
1001,11,1001000111,TwS,Hydroxychloroquine  with Index date: Jan 2020
1002,11,1002000111,TwS,Hydroxychloroquine + Azithromycin  with Index date: Jan 2020
1003,11,1003000111,TwS,Hydroxychloroquine + Fluoroquinolones with Index date: Jan 2020
1004,11,1004000111,TwS,Hydroxychloroquine + Amoxicillin with Index date: Jan 2020
1005,11,1005000111,TwS,Hydroxychloroquine + ceftriaxone with Index date: Jan 2020
1006,11,1006000111,TwS,Chloroquine with Index date: Jan 2020
1007,11,1007000111,TwS,Azithromycin with Index date: Jan 2020
1008,11,1008000111,TwS,Fluoroquinolones with Index date: Jan 2020
1009,11,1009000111,TwS,Amoxicillin with Index date: Jan 2020
1010,11,1010000111,TwS,Ceftriaxone with Index date: Jan 2020
1011,11,1011000111,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with Index date: Jan 2020"
1012,11,1012000111,TwS,tocilizumab with Index date: Jan 2020
1013,11,1013000111,TwS,siltuximab with Index date: Jan 2020
1014,11,1014000111,TwS,sarilumab with Index date: Jan 2020
1015,11,1015000111,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with Index date: Jan 2020"
1016,11,1016000111,TwS,baricitinib with Index date: Jan 2020
1017,11,1017000111,TwS,tofacitinib with Index date: Jan 2020
1018,11,1018000111,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with Index date: Jan 2020"
1019,11,1019000111,TwS,adalimumab with Index date: Jan 2020
1020,11,1020000111,TwS,etanercept with Index date: Jan 2020
1021,11,1021000111,TwS,infliximab with Index date: Jan 2020
1022,11,1022000111,TwS,ustekinumab with Index date: Jan 2020
1023,11,1023000111,TwS,Anakinra with Index date: Jan 2020
1024,11,1024000111,TwS,HIV Protease inhibitors with Index date: Jan 2020
1025,11,1025000111,TwS,ritonavir/lopinavir with Index date: Jan 2020
1026,11,1026000111,TwS,Interferon beta 1b with Index date: Jan 2020
1027,11,1027000111,TwS,Interferon beta 1a with Index date: Jan 2020
1028,11,1028000111,TwS,Interferon beta 1a with Index date: Jan 2020
1029,11,1029000111,TwS,favipiravir with Index date: Jan 2020
1030,11,1030000111,TwS,Remdesivir with Index date: Jan 2020
1031,11,1031000111,TwS,ribavirin with Index date: Jan 2020
1032,11,1032000111,TwS,oseltamivir with Index date: Jan 2020
1033,11,1033000111,TwS,Ivermectin with Index date: Jan 2020
1034,11,1034000111,TwS,itraconazole with Index date: Jan 2020
1035,11,1035000111,TwS,warfarin with Index date: Jan 2020
1036,11,1036000111,TwS,heparin with Index date: Jan 2020
1037,11,1037000111,TwS,enoxaparin with Index date: Jan 2020
1038,11,1038000111,TwS,edoxaban with Index date: Jan 2020
1039,11,1039000111,TwS,dabigatran with Index date: Jan 2020
1040,11,1040000111,TwS,rivaroxaban with Index date: Jan 2020
1041,11,1041000111,TwS,acenocoumarol with Index date: Jan 2020
1042,11,1042000111,TwS,apixaban with Index date: Jan 2020
1043,11,1043000111,TwS,bemiparin with Index date: Jan 2020
1044,11,1044000111,TwS,clopidogrel with Index date: Jan 2020
1045,11,1045000111,TwS,aspirin with Index date: Jan 2020
1046,11,1046000111,TwS,prasugrel with Index date: Jan 2020
1047,11,1047000111,TwS,alteplase with Index date: Jan 2020
1048,11,1048000111,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with Index date: Jan 2020"
1049,11,1049000111,TwS,tranexamic acid with Index date: Jan 2020
1050,11,1050000111,TwS,Ruxolitinib with Index date: Jan 2020
1051,11,1051000111,TwS,Siltuximab with Index date: Jan 2020
1052,11,1052000111,TwS,ACE inhibitors with Index date: Jan 2020
1053,11,1053000111,TwS,Angiotensin receptor blockers (ARBs) with Index date: Jan 2020
1054,11,1054000111,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with Index date: Jan 2020
1055,11,1055000111,TwS,Thiazide or thiazide-like diuretics with Index date: Jan 2020
1056,11,1056000111,TwS,Hydrocortisone with Index date: Jan 2020
1057,11,1057000111,TwS,dexamethasone with Index date: Jan 2020
1058,11,1058000111,TwS,prednisone or prednisolone with Index date: Jan 2020
1059,11,1059000111,TwS,raloxifene with Index date: Jan 2020
1060,11,1060000111,TwS,Bevacizumab with Index date: Jan 2020
1061,11,1061000111,TwS,Fingolimod with Index date: Jan 2020
1062,11,1062000111,TwS,eculizumab  with Index date: Jan 2020
1063,11,1063000111,TwS,Statins with Index date: Jan 2020
1064,11,1064000111,TwS,metformin with Index date: Jan 2020
1065,11,1065000111,TwS,DPP-4 inhibitors with Index date: Jan 2020
1066,11,1066000111,TwS,SGLT2 inhibitors with Index date: Jan 2020
1067,11,1067000111,TwS,GLP1 inhibitors with Index date: Jan 2020
1068,11,1068000111,TwS,H2 receptor antagonist with Index date: Jan 2020
1069,11,1069000111,TwS,famotidine with Index date: Jan 2020
1070,11,1070000111,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with Index date: Jan 2020"
1071,11,1071000111,TwS,prazosin with Index date: Jan 2020
1072,11,1072000111,TwS,terazosin with Index date: Jan 2020
1073,11,1073000111,TwS,doxazosin with Index date: Jan 2020
1074,11,1074000111,TwS,tamsulosin with Index date: Jan 2020
1075,11,1075000111,TwS,BCG vaccine with Index date: Jan 2020
1076,11,1076000111,TwS,Colchicine with Index date: Jan 2020
1077,11,1077000111,TwS,Losartan with Index date: Jan 2020
1078,11,1078000111,TwS,cholecalciferol with Index date: Jan 2020
1079,11,1079000111,TwS,Ibrutinib with Index date: Jan 2020
1080,11,1080000111,TwS,abiraterone with Index date: Jan 2020
1081,11,1081000111,TwS,bicalutamide with Index date: Jan 2020
1082,11,1082000111,TwS,emtricitabine with Index date: Jan 2020
1083,11,1083000111,TwS,tacrolimus with Index date: Jan 2020
1001,12,1001000121,TwS,Hydroxychloroquine  with Index date: Feb 2020
1002,12,1002000121,TwS,Hydroxychloroquine + Azithromycin  with Index date: Feb 2020
1003,12,1003000121,TwS,Hydroxychloroquine + Fluoroquinolones with Index date: Feb 2020
1004,12,1004000121,TwS,Hydroxychloroquine + Amoxicillin with Index date: Feb 2020
1005,12,1005000121,TwS,Hydroxychloroquine + ceftriaxone with Index date: Feb 2020
1006,12,1006000121,TwS,Chloroquine with Index date: Feb 2020
1007,12,1007000121,TwS,Azithromycin with Index date: Feb 2020
1008,12,1008000121,TwS,Fluoroquinolones with Index date: Feb 2020
1009,12,1009000121,TwS,Amoxicillin with Index date: Feb 2020
1010,12,1010000121,TwS,Ceftriaxone with Index date: Feb 2020
1011,12,1011000121,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with Index date: Feb 2020"
1012,12,1012000121,TwS,tocilizumab with Index date: Feb 2020
1013,12,1013000121,TwS,siltuximab with Index date: Feb 2020
1014,12,1014000121,TwS,sarilumab with Index date: Feb 2020
1015,12,1015000121,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with Index date: Feb 2020"
1016,12,1016000121,TwS,baricitinib with Index date: Feb 2020
1017,12,1017000121,TwS,tofacitinib with Index date: Feb 2020
1018,12,1018000121,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with Index date: Feb 2020"
1019,12,1019000121,TwS,adalimumab with Index date: Feb 2020
1020,12,1020000121,TwS,etanercept with Index date: Feb 2020
1021,12,1021000121,TwS,infliximab with Index date: Feb 2020
1022,12,1022000121,TwS,ustekinumab with Index date: Feb 2020
1023,12,1023000121,TwS,Anakinra with Index date: Feb 2020
1024,12,1024000121,TwS,HIV Protease inhibitors with Index date: Feb 2020
1025,12,1025000121,TwS,ritonavir/lopinavir with Index date: Feb 2020
1026,12,1026000121,TwS,Interferon beta 1b with Index date: Feb 2020
1027,12,1027000121,TwS,Interferon beta 1a with Index date: Feb 2020
1028,12,1028000121,TwS,Interferon beta 1a with Index date: Feb 2020
1029,12,1029000121,TwS,favipiravir with Index date: Feb 2020
1030,12,1030000121,TwS,Remdesivir with Index date: Feb 2020
1031,12,1031000121,TwS,ribavirin with Index date: Feb 2020
1032,12,1032000121,TwS,oseltamivir with Index date: Feb 2020
1033,12,1033000121,TwS,Ivermectin with Index date: Feb 2020
1034,12,1034000121,TwS,itraconazole with Index date: Feb 2020
1035,12,1035000121,TwS,warfarin with Index date: Feb 2020
1036,12,1036000121,TwS,heparin with Index date: Feb 2020
1037,12,1037000121,TwS,enoxaparin with Index date: Feb 2020
1038,12,1038000121,TwS,edoxaban with Index date: Feb 2020
1039,12,1039000121,TwS,dabigatran with Index date: Feb 2020
1040,12,1040000121,TwS,rivaroxaban with Index date: Feb 2020
1041,12,1041000121,TwS,acenocoumarol with Index date: Feb 2020
1042,12,1042000121,TwS,apixaban with Index date: Feb 2020
1043,12,1043000121,TwS,bemiparin with Index date: Feb 2020
1044,12,1044000121,TwS,clopidogrel with Index date: Feb 2020
1045,12,1045000121,TwS,aspirin with Index date: Feb 2020
1046,12,1046000121,TwS,prasugrel with Index date: Feb 2020
1047,12,1047000121,TwS,alteplase with Index date: Feb 2020
1048,12,1048000121,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with Index date: Feb 2020"
1049,12,1049000121,TwS,tranexamic acid with Index date: Feb 2020
1050,12,1050000121,TwS,Ruxolitinib with Index date: Feb 2020
1051,12,1051000121,TwS,Siltuximab with Index date: Feb 2020
1052,12,1052000121,TwS,ACE inhibitors with Index date: Feb 2020
1053,12,1053000121,TwS,Angiotensin receptor blockers (ARBs) with Index date: Feb 2020
1054,12,1054000121,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with Index date: Feb 2020
1055,12,1055000121,TwS,Thiazide or thiazide-like diuretics with Index date: Feb 2020
1056,12,1056000121,TwS,Hydrocortisone with Index date: Feb 2020
1057,12,1057000121,TwS,dexamethasone with Index date: Feb 2020
1058,12,1058000121,TwS,prednisone or prednisolone with Index date: Feb 2020
1059,12,1059000121,TwS,raloxifene with Index date: Feb 2020
1060,12,1060000121,TwS,Bevacizumab with Index date: Feb 2020
1061,12,1061000121,TwS,Fingolimod with Index date: Feb 2020
1062,12,1062000121,TwS,eculizumab  with Index date: Feb 2020
1063,12,1063000121,TwS,Statins with Index date: Feb 2020
1064,12,1064000121,TwS,metformin with Index date: Feb 2020
1065,12,1065000121,TwS,DPP-4 inhibitors with Index date: Feb 2020
1066,12,1066000121,TwS,SGLT2 inhibitors with Index date: Feb 2020
1067,12,1067000121,TwS,GLP1 inhibitors with Index date: Feb 2020
1068,12,1068000121,TwS,H2 receptor antagonist with Index date: Feb 2020
1069,12,1069000121,TwS,famotidine with Index date: Feb 2020
1070,12,1070000121,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with Index date: Feb 2020"
1071,12,1071000121,TwS,prazosin with Index date: Feb 2020
1072,12,1072000121,TwS,terazosin with Index date: Feb 2020
1073,12,1073000121,TwS,doxazosin with Index date: Feb 2020
1074,12,1074000121,TwS,tamsulosin with Index date: Feb 2020
1075,12,1075000121,TwS,BCG vaccine with Index date: Feb 2020
1076,12,1076000121,TwS,Colchicine with Index date: Feb 2020
1077,12,1077000121,TwS,Losartan with Index date: Feb 2020
1078,12,1078000121,TwS,cholecalciferol with Index date: Feb 2020
1079,12,1079000121,TwS,Ibrutinib with Index date: Feb 2020
1080,12,1080000121,TwS,abiraterone with Index date: Feb 2020
1081,12,1081000121,TwS,bicalutamide with Index date: Feb 2020
1082,12,1082000121,TwS,emtricitabine with Index date: Feb 2020
1083,12,1083000121,TwS,tacrolimus with Index date: Feb 2020
1001,13,1001000131,TwS,Hydroxychloroquine  with Index date: Mar 2020
1002,13,1002000131,TwS,Hydroxychloroquine + Azithromycin  with Index date: Mar 2020
1003,13,1003000131,TwS,Hydroxychloroquine + Fluoroquinolones with Index date: Mar 2020
1004,13,1004000131,TwS,Hydroxychloroquine + Amoxicillin with Index date: Mar 2020
1005,13,1005000131,TwS,Hydroxychloroquine + ceftriaxone with Index date: Mar 2020
1006,13,1006000131,TwS,Chloroquine with Index date: Mar 2020
1007,13,1007000131,TwS,Azithromycin with Index date: Mar 2020
1008,13,1008000131,TwS,Fluoroquinolones with Index date: Mar 2020
1009,13,1009000131,TwS,Amoxicillin with Index date: Mar 2020
1010,13,1010000131,TwS,Ceftriaxone with Index date: Mar 2020
1011,13,1011000131,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with Index date: Mar 2020"
1012,13,1012000131,TwS,tocilizumab with Index date: Mar 2020
1013,13,1013000131,TwS,siltuximab with Index date: Mar 2020
1014,13,1014000131,TwS,sarilumab with Index date: Mar 2020
1015,13,1015000131,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with Index date: Mar 2020"
1016,13,1016000131,TwS,baricitinib with Index date: Mar 2020
1017,13,1017000131,TwS,tofacitinib with Index date: Mar 2020
1018,13,1018000131,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with Index date: Mar 2020"
1019,13,1019000131,TwS,adalimumab with Index date: Mar 2020
1020,13,1020000131,TwS,etanercept with Index date: Mar 2020
1021,13,1021000131,TwS,infliximab with Index date: Mar 2020
1022,13,1022000131,TwS,ustekinumab with Index date: Mar 2020
1023,13,1023000131,TwS,Anakinra with Index date: Mar 2020
1024,13,1024000131,TwS,HIV Protease inhibitors with Index date: Mar 2020
1025,13,1025000131,TwS,ritonavir/lopinavir with Index date: Mar 2020
1026,13,1026000131,TwS,Interferon beta 1b with Index date: Mar 2020
1027,13,1027000131,TwS,Interferon beta 1a with Index date: Mar 2020
1028,13,1028000131,TwS,Interferon beta 1a with Index date: Mar 2020
1029,13,1029000131,TwS,favipiravir with Index date: Mar 2020
1030,13,1030000131,TwS,Remdesivir with Index date: Mar 2020
1031,13,1031000131,TwS,ribavirin with Index date: Mar 2020
1032,13,1032000131,TwS,oseltamivir with Index date: Mar 2020
1033,13,1033000131,TwS,Ivermectin with Index date: Mar 2020
1034,13,1034000131,TwS,itraconazole with Index date: Mar 2020
1035,13,1035000131,TwS,warfarin with Index date: Mar 2020
1036,13,1036000131,TwS,heparin with Index date: Mar 2020
1037,13,1037000131,TwS,enoxaparin with Index date: Mar 2020
1038,13,1038000131,TwS,edoxaban with Index date: Mar 2020
1039,13,1039000131,TwS,dabigatran with Index date: Mar 2020
1040,13,1040000131,TwS,rivaroxaban with Index date: Mar 2020
1041,13,1041000131,TwS,acenocoumarol with Index date: Mar 2020
1042,13,1042000131,TwS,apixaban with Index date: Mar 2020
1043,13,1043000131,TwS,bemiparin with Index date: Mar 2020
1044,13,1044000131,TwS,clopidogrel with Index date: Mar 2020
1045,13,1045000131,TwS,aspirin with Index date: Mar 2020
1046,13,1046000131,TwS,prasugrel with Index date: Mar 2020
1047,13,1047000131,TwS,alteplase with Index date: Mar 2020
1048,13,1048000131,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with Index date: Mar 2020"
1049,13,1049000131,TwS,tranexamic acid with Index date: Mar 2020
1050,13,1050000131,TwS,Ruxolitinib with Index date: Mar 2020
1051,13,1051000131,TwS,Siltuximab with Index date: Mar 2020
1052,13,1052000131,TwS,ACE inhibitors with Index date: Mar 2020
1053,13,1053000131,TwS,Angiotensin receptor blockers (ARBs) with Index date: Mar 2020
1054,13,1054000131,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with Index date: Mar 2020
1055,13,1055000131,TwS,Thiazide or thiazide-like diuretics with Index date: Mar 2020
1056,13,1056000131,TwS,Hydrocortisone with Index date: Mar 2020
1057,13,1057000131,TwS,dexamethasone with Index date: Mar 2020
1058,13,1058000131,TwS,prednisone or prednisolone with Index date: Mar 2020
1059,13,1059000131,TwS,raloxifene with Index date: Mar 2020
1060,13,1060000131,TwS,Bevacizumab with Index date: Mar 2020
1061,13,1061000131,TwS,Fingolimod with Index date: Mar 2020
1062,13,1062000131,TwS,eculizumab  with Index date: Mar 2020
1063,13,1063000131,TwS,Statins with Index date: Mar 2020
1064,13,1064000131,TwS,metformin with Index date: Mar 2020
1065,13,1065000131,TwS,DPP-4 inhibitors with Index date: Mar 2020
1066,13,1066000131,TwS,SGLT2 inhibitors with Index date: Mar 2020
1067,13,1067000131,TwS,GLP1 inhibitors with Index date: Mar 2020
1068,13,1068000131,TwS,H2 receptor antagonist with Index date: Mar 2020
1069,13,1069000131,TwS,famotidine with Index date: Mar 2020
1070,13,1070000131,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with Index date: Mar 2020"
1071,13,1071000131,TwS,prazosin with Index date: Mar 2020
1072,13,1072000131,TwS,terazosin with Index date: Mar 2020
1073,13,1073000131,TwS,doxazosin with Index date: Mar 2020
1074,13,1074000131,TwS,tamsulosin with Index date: Mar 2020
1075,13,1075000131,TwS,BCG vaccine with Index date: Mar 2020
1076,13,1076000131,TwS,Colchicine with Index date: Mar 2020
1077,13,1077000131,TwS,Losartan with Index date: Mar 2020
1078,13,1078000131,TwS,cholecalciferol with Index date: Mar 2020
1079,13,1079000131,TwS,Ibrutinib with Index date: Mar 2020
1080,13,1080000131,TwS,abiraterone with Index date: Mar 2020
1081,13,1081000131,TwS,bicalutamide with Index date: Mar 2020
1082,13,1082000131,TwS,emtricitabine with Index date: Mar 2020
1083,13,1083000131,TwS,tacrolimus with Index date: Mar 2020
1001,14,1001000141,TwS,Hydroxychloroquine  with Index date: Apr 2020
1002,14,1002000141,TwS,Hydroxychloroquine + Azithromycin  with Index date: Apr 2020
1003,14,1003000141,TwS,Hydroxychloroquine + Fluoroquinolones with Index date: Apr 2020
1004,14,1004000141,TwS,Hydroxychloroquine + Amoxicillin with Index date: Apr 2020
1005,14,1005000141,TwS,Hydroxychloroquine + ceftriaxone with Index date: Apr 2020
1006,14,1006000141,TwS,Chloroquine with Index date: Apr 2020
1007,14,1007000141,TwS,Azithromycin with Index date: Apr 2020
1008,14,1008000141,TwS,Fluoroquinolones with Index date: Apr 2020
1009,14,1009000141,TwS,Amoxicillin with Index date: Apr 2020
1010,14,1010000141,TwS,Ceftriaxone with Index date: Apr 2020
1011,14,1011000141,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with Index date: Apr 2020"
1012,14,1012000141,TwS,tocilizumab with Index date: Apr 2020
1013,14,1013000141,TwS,siltuximab with Index date: Apr 2020
1014,14,1014000141,TwS,sarilumab with Index date: Apr 2020
1015,14,1015000141,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with Index date: Apr 2020"
1016,14,1016000141,TwS,baricitinib with Index date: Apr 2020
1017,14,1017000141,TwS,tofacitinib with Index date: Apr 2020
1018,14,1018000141,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with Index date: Apr 2020"
1019,14,1019000141,TwS,adalimumab with Index date: Apr 2020
1020,14,1020000141,TwS,etanercept with Index date: Apr 2020
1021,14,1021000141,TwS,infliximab with Index date: Apr 2020
1022,14,1022000141,TwS,ustekinumab with Index date: Apr 2020
1023,14,1023000141,TwS,Anakinra with Index date: Apr 2020
1024,14,1024000141,TwS,HIV Protease inhibitors with Index date: Apr 2020
1025,14,1025000141,TwS,ritonavir/lopinavir with Index date: Apr 2020
1026,14,1026000141,TwS,Interferon beta 1b with Index date: Apr 2020
1027,14,1027000141,TwS,Interferon beta 1a with Index date: Apr 2020
1028,14,1028000141,TwS,Interferon beta 1a with Index date: Apr 2020
1029,14,1029000141,TwS,favipiravir with Index date: Apr 2020
1030,14,1030000141,TwS,Remdesivir with Index date: Apr 2020
1031,14,1031000141,TwS,ribavirin with Index date: Apr 2020
1032,14,1032000141,TwS,oseltamivir with Index date: Apr 2020
1033,14,1033000141,TwS,Ivermectin with Index date: Apr 2020
1034,14,1034000141,TwS,itraconazole with Index date: Apr 2020
1035,14,1035000141,TwS,warfarin with Index date: Apr 2020
1036,14,1036000141,TwS,heparin with Index date: Apr 2020
1037,14,1037000141,TwS,enoxaparin with Index date: Apr 2020
1038,14,1038000141,TwS,edoxaban with Index date: Apr 2020
1039,14,1039000141,TwS,dabigatran with Index date: Apr 2020
1040,14,1040000141,TwS,rivaroxaban with Index date: Apr 2020
1041,14,1041000141,TwS,acenocoumarol with Index date: Apr 2020
1042,14,1042000141,TwS,apixaban with Index date: Apr 2020
1043,14,1043000141,TwS,bemiparin with Index date: Apr 2020
1044,14,1044000141,TwS,clopidogrel with Index date: Apr 2020
1045,14,1045000141,TwS,aspirin with Index date: Apr 2020
1046,14,1046000141,TwS,prasugrel with Index date: Apr 2020
1047,14,1047000141,TwS,alteplase with Index date: Apr 2020
1048,14,1048000141,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with Index date: Apr 2020"
1049,14,1049000141,TwS,tranexamic acid with Index date: Apr 2020
1050,14,1050000141,TwS,Ruxolitinib with Index date: Apr 2020
1051,14,1051000141,TwS,Siltuximab with Index date: Apr 2020
1052,14,1052000141,TwS,ACE inhibitors with Index date: Apr 2020
1053,14,1053000141,TwS,Angiotensin receptor blockers (ARBs) with Index date: Apr 2020
1054,14,1054000141,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with Index date: Apr 2020
1055,14,1055000141,TwS,Thiazide or thiazide-like diuretics with Index date: Apr 2020
1056,14,1056000141,TwS,Hydrocortisone with Index date: Apr 2020
1057,14,1057000141,TwS,dexamethasone with Index date: Apr 2020
1058,14,1058000141,TwS,prednisone or prednisolone with Index date: Apr 2020
1059,14,1059000141,TwS,raloxifene with Index date: Apr 2020
1060,14,1060000141,TwS,Bevacizumab with Index date: Apr 2020
1061,14,1061000141,TwS,Fingolimod with Index date: Apr 2020
1062,14,1062000141,TwS,eculizumab  with Index date: Apr 2020
1063,14,1063000141,TwS,Statins with Index date: Apr 2020
1064,14,1064000141,TwS,metformin with Index date: Apr 2020
1065,14,1065000141,TwS,DPP-4 inhibitors with Index date: Apr 2020
1066,14,1066000141,TwS,SGLT2 inhibitors with Index date: Apr 2020
1067,14,1067000141,TwS,GLP1 inhibitors with Index date: Apr 2020
1068,14,1068000141,TwS,H2 receptor antagonist with Index date: Apr 2020
1069,14,1069000141,TwS,famotidine with Index date: Apr 2020
1070,14,1070000141,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with Index date: Apr 2020"
1071,14,1071000141,TwS,prazosin with Index date: Apr 2020
1072,14,1072000141,TwS,terazosin with Index date: Apr 2020
1073,14,1073000141,TwS,doxazosin with Index date: Apr 2020
1074,14,1074000141,TwS,tamsulosin with Index date: Apr 2020
1075,14,1075000141,TwS,BCG vaccine with Index date: Apr 2020
1076,14,1076000141,TwS,Colchicine with Index date: Apr 2020
1077,14,1077000141,TwS,Losartan with Index date: Apr 2020
1078,14,1078000141,TwS,cholecalciferol with Index date: Apr 2020
1079,14,1079000141,TwS,Ibrutinib with Index date: Apr 2020
1080,14,1080000141,TwS,abiraterone with Index date: Apr 2020
1081,14,1081000141,TwS,bicalutamide with Index date: Apr 2020
1082,14,1082000141,TwS,emtricitabine with Index date: Apr 2020
1083,14,1083000141,TwS,tacrolimus with Index date: Apr 2020
1001,15,1001000151,TwS,Hydroxychloroquine  with Index date: May 2020
1002,15,1002000151,TwS,Hydroxychloroquine + Azithromycin  with Index date: May 2020
1003,15,1003000151,TwS,Hydroxychloroquine + Fluoroquinolones with Index date: May 2020
1004,15,1004000151,TwS,Hydroxychloroquine + Amoxicillin with Index date: May 2020
1005,15,1005000151,TwS,Hydroxychloroquine + ceftriaxone with Index date: May 2020
1006,15,1006000151,TwS,Chloroquine with Index date: May 2020
1007,15,1007000151,TwS,Azithromycin with Index date: May 2020
1008,15,1008000151,TwS,Fluoroquinolones with Index date: May 2020
1009,15,1009000151,TwS,Amoxicillin with Index date: May 2020
1010,15,1010000151,TwS,Ceftriaxone with Index date: May 2020
1011,15,1011000151,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with Index date: May 2020"
1012,15,1012000151,TwS,tocilizumab with Index date: May 2020
1013,15,1013000151,TwS,siltuximab with Index date: May 2020
1014,15,1014000151,TwS,sarilumab with Index date: May 2020
1015,15,1015000151,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with Index date: May 2020"
1016,15,1016000151,TwS,baricitinib with Index date: May 2020
1017,15,1017000151,TwS,tofacitinib with Index date: May 2020
1018,15,1018000151,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with Index date: May 2020"
1019,15,1019000151,TwS,adalimumab with Index date: May 2020
1020,15,1020000151,TwS,etanercept with Index date: May 2020
1021,15,1021000151,TwS,infliximab with Index date: May 2020
1022,15,1022000151,TwS,ustekinumab with Index date: May 2020
1023,15,1023000151,TwS,Anakinra with Index date: May 2020
1024,15,1024000151,TwS,HIV Protease inhibitors with Index date: May 2020
1025,15,1025000151,TwS,ritonavir/lopinavir with Index date: May 2020
1026,15,1026000151,TwS,Interferon beta 1b with Index date: May 2020
1027,15,1027000151,TwS,Interferon beta 1a with Index date: May 2020
1028,15,1028000151,TwS,Interferon beta 1a with Index date: May 2020
1029,15,1029000151,TwS,favipiravir with Index date: May 2020
1030,15,1030000151,TwS,Remdesivir with Index date: May 2020
1031,15,1031000151,TwS,ribavirin with Index date: May 2020
1032,15,1032000151,TwS,oseltamivir with Index date: May 2020
1033,15,1033000151,TwS,Ivermectin with Index date: May 2020
1034,15,1034000151,TwS,itraconazole with Index date: May 2020
1035,15,1035000151,TwS,warfarin with Index date: May 2020
1036,15,1036000151,TwS,heparin with Index date: May 2020
1037,15,1037000151,TwS,enoxaparin with Index date: May 2020
1038,15,1038000151,TwS,edoxaban with Index date: May 2020
1039,15,1039000151,TwS,dabigatran with Index date: May 2020
1040,15,1040000151,TwS,rivaroxaban with Index date: May 2020
1041,15,1041000151,TwS,acenocoumarol with Index date: May 2020
1042,15,1042000151,TwS,apixaban with Index date: May 2020
1043,15,1043000151,TwS,bemiparin with Index date: May 2020
1044,15,1044000151,TwS,clopidogrel with Index date: May 2020
1045,15,1045000151,TwS,aspirin with Index date: May 2020
1046,15,1046000151,TwS,prasugrel with Index date: May 2020
1047,15,1047000151,TwS,alteplase with Index date: May 2020
1048,15,1048000151,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with Index date: May 2020"
1049,15,1049000151,TwS,tranexamic acid with Index date: May 2020
1050,15,1050000151,TwS,Ruxolitinib with Index date: May 2020
1051,15,1051000151,TwS,Siltuximab with Index date: May 2020
1052,15,1052000151,TwS,ACE inhibitors with Index date: May 2020
1053,15,1053000151,TwS,Angiotensin receptor blockers (ARBs) with Index date: May 2020
1054,15,1054000151,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with Index date: May 2020
1055,15,1055000151,TwS,Thiazide or thiazide-like diuretics with Index date: May 2020
1056,15,1056000151,TwS,Hydrocortisone with Index date: May 2020
1057,15,1057000151,TwS,dexamethasone with Index date: May 2020
1058,15,1058000151,TwS,prednisone or prednisolone with Index date: May 2020
1059,15,1059000151,TwS,raloxifene with Index date: May 2020
1060,15,1060000151,TwS,Bevacizumab with Index date: May 2020
1061,15,1061000151,TwS,Fingolimod with Index date: May 2020
1062,15,1062000151,TwS,eculizumab  with Index date: May 2020
1063,15,1063000151,TwS,Statins with Index date: May 2020
1064,15,1064000151,TwS,metformin with Index date: May 2020
1065,15,1065000151,TwS,DPP-4 inhibitors with Index date: May 2020
1066,15,1066000151,TwS,SGLT2 inhibitors with Index date: May 2020
1067,15,1067000151,TwS,GLP1 inhibitors with Index date: May 2020
1068,15,1068000151,TwS,H2 receptor antagonist with Index date: May 2020
1069,15,1069000151,TwS,famotidine with Index date: May 2020
1070,15,1070000151,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with Index date: May 2020"
1071,15,1071000151,TwS,prazosin with Index date: May 2020
1072,15,1072000151,TwS,terazosin with Index date: May 2020
1073,15,1073000151,TwS,doxazosin with Index date: May 2020
1074,15,1074000151,TwS,tamsulosin with Index date: May 2020
1075,15,1075000151,TwS,BCG vaccine with Index date: May 2020
1076,15,1076000151,TwS,Colchicine with Index date: May 2020
1077,15,1077000151,TwS,Losartan with Index date: May 2020
1078,15,1078000151,TwS,cholecalciferol with Index date: May 2020
1079,15,1079000151,TwS,Ibrutinib with Index date: May 2020
1080,15,1080000151,TwS,abiraterone with Index date: May 2020
1081,15,1081000151,TwS,bicalutamide with Index date: May 2020
1082,15,1082000151,TwS,emtricitabine with Index date: May 2020
1083,15,1083000151,TwS,tacrolimus with Index date: May 2020
1001,16,1001000161,TwS,Hydroxychloroquine  with Index date: Jun 2020
1002,16,1002000161,TwS,Hydroxychloroquine + Azithromycin  with Index date: Jun 2020
1003,16,1003000161,TwS,Hydroxychloroquine + Fluoroquinolones with Index date: Jun 2020
1004,16,1004000161,TwS,Hydroxychloroquine + Amoxicillin with Index date: Jun 2020
1005,16,1005000161,TwS,Hydroxychloroquine + ceftriaxone with Index date: Jun 2020
1006,16,1006000161,TwS,Chloroquine with Index date: Jun 2020
1007,16,1007000161,TwS,Azithromycin with Index date: Jun 2020
1008,16,1008000161,TwS,Fluoroquinolones with Index date: Jun 2020
1009,16,1009000161,TwS,Amoxicillin with Index date: Jun 2020
1010,16,1010000161,TwS,Ceftriaxone with Index date: Jun 2020
1011,16,1011000161,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with Index date: Jun 2020"
1012,16,1012000161,TwS,tocilizumab with Index date: Jun 2020
1013,16,1013000161,TwS,siltuximab with Index date: Jun 2020
1014,16,1014000161,TwS,sarilumab with Index date: Jun 2020
1015,16,1015000161,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with Index date: Jun 2020"
1016,16,1016000161,TwS,baricitinib with Index date: Jun 2020
1017,16,1017000161,TwS,tofacitinib with Index date: Jun 2020
1018,16,1018000161,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with Index date: Jun 2020"
1019,16,1019000161,TwS,adalimumab with Index date: Jun 2020
1020,16,1020000161,TwS,etanercept with Index date: Jun 2020
1021,16,1021000161,TwS,infliximab with Index date: Jun 2020
1022,16,1022000161,TwS,ustekinumab with Index date: Jun 2020
1023,16,1023000161,TwS,Anakinra with Index date: Jun 2020
1024,16,1024000161,TwS,HIV Protease inhibitors with Index date: Jun 2020
1025,16,1025000161,TwS,ritonavir/lopinavir with Index date: Jun 2020
1026,16,1026000161,TwS,Interferon beta 1b with Index date: Jun 2020
1027,16,1027000161,TwS,Interferon beta 1a with Index date: Jun 2020
1028,16,1028000161,TwS,Interferon beta 1a with Index date: Jun 2020
1029,16,1029000161,TwS,favipiravir with Index date: Jun 2020
1030,16,1030000161,TwS,Remdesivir with Index date: Jun 2020
1031,16,1031000161,TwS,ribavirin with Index date: Jun 2020
1032,16,1032000161,TwS,oseltamivir with Index date: Jun 2020
1033,16,1033000161,TwS,Ivermectin with Index date: Jun 2020
1034,16,1034000161,TwS,itraconazole with Index date: Jun 2020
1035,16,1035000161,TwS,warfarin with Index date: Jun 2020
1036,16,1036000161,TwS,heparin with Index date: Jun 2020
1037,16,1037000161,TwS,enoxaparin with Index date: Jun 2020
1038,16,1038000161,TwS,edoxaban with Index date: Jun 2020
1039,16,1039000161,TwS,dabigatran with Index date: Jun 2020
1040,16,1040000161,TwS,rivaroxaban with Index date: Jun 2020
1041,16,1041000161,TwS,acenocoumarol with Index date: Jun 2020
1042,16,1042000161,TwS,apixaban with Index date: Jun 2020
1043,16,1043000161,TwS,bemiparin with Index date: Jun 2020
1044,16,1044000161,TwS,clopidogrel with Index date: Jun 2020
1045,16,1045000161,TwS,aspirin with Index date: Jun 2020
1046,16,1046000161,TwS,prasugrel with Index date: Jun 2020
1047,16,1047000161,TwS,alteplase with Index date: Jun 2020
1048,16,1048000161,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with Index date: Jun 2020"
1049,16,1049000161,TwS,tranexamic acid with Index date: Jun 2020
1050,16,1050000161,TwS,Ruxolitinib with Index date: Jun 2020
1051,16,1051000161,TwS,Siltuximab with Index date: Jun 2020
1052,16,1052000161,TwS,ACE inhibitors with Index date: Jun 2020
1053,16,1053000161,TwS,Angiotensin receptor blockers (ARBs) with Index date: Jun 2020
1054,16,1054000161,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with Index date: Jun 2020
1055,16,1055000161,TwS,Thiazide or thiazide-like diuretics with Index date: Jun 2020
1056,16,1056000161,TwS,Hydrocortisone with Index date: Jun 2020
1057,16,1057000161,TwS,dexamethasone with Index date: Jun 2020
1058,16,1058000161,TwS,prednisone or prednisolone with Index date: Jun 2020
1059,16,1059000161,TwS,raloxifene with Index date: Jun 2020
1060,16,1060000161,TwS,Bevacizumab with Index date: Jun 2020
1061,16,1061000161,TwS,Fingolimod with Index date: Jun 2020
1062,16,1062000161,TwS,eculizumab  with Index date: Jun 2020
1063,16,1063000161,TwS,Statins with Index date: Jun 2020
1064,16,1064000161,TwS,metformin with Index date: Jun 2020
1065,16,1065000161,TwS,DPP-4 inhibitors with Index date: Jun 2020
1066,16,1066000161,TwS,SGLT2 inhibitors with Index date: Jun 2020
1067,16,1067000161,TwS,GLP1 inhibitors with Index date: Jun 2020
1068,16,1068000161,TwS,H2 receptor antagonist with Index date: Jun 2020
1069,16,1069000161,TwS,famotidine with Index date: Jun 2020
1070,16,1070000161,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with Index date: Jun 2020"
1071,16,1071000161,TwS,prazosin with Index date: Jun 2020
1072,16,1072000161,TwS,terazosin with Index date: Jun 2020
1073,16,1073000161,TwS,doxazosin with Index date: Jun 2020
1074,16,1074000161,TwS,tamsulosin with Index date: Jun 2020
1075,16,1075000161,TwS,BCG vaccine with Index date: Jun 2020
1076,16,1076000161,TwS,Colchicine with Index date: Jun 2020
1077,16,1077000161,TwS,Losartan with Index date: Jun 2020
1078,16,1078000161,TwS,cholecalciferol with Index date: Jun 2020
1079,16,1079000161,TwS,Ibrutinib with Index date: Jun 2020
1080,16,1080000161,TwS,abiraterone with Index date: Jun 2020
1081,16,1081000161,TwS,bicalutamide with Index date: Jun 2020
1082,16,1082000161,TwS,emtricitabine with Index date: Jun 2020
1083,16,1083000161,TwS,tacrolimus with Index date: Jun 2020
1001,2001,1001020011,TwS,Hydroxychloroquine  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1002,2001,1002020011,TwS,Hydroxychloroquine + Azithromycin  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1003,2001,1003020011,TwS,Hydroxychloroquine + Fluoroquinolones with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1004,2001,1004020011,TwS,Hydroxychloroquine + Amoxicillin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1005,2001,1005020011,TwS,Hydroxychloroquine + ceftriaxone with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1006,2001,1006020011,TwS,Chloroquine with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1007,2001,1007020011,TwS,Azithromycin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1008,2001,1008020011,TwS,Fluoroquinolones with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1009,2001,1009020011,TwS,Amoxicillin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1010,2001,1010020011,TwS,Ceftriaxone with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1011,2001,1011020011,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services"
1012,2001,1012020011,TwS,tocilizumab with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1013,2001,1013020011,TwS,siltuximab with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1014,2001,1014020011,TwS,sarilumab with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1015,2001,1015020011,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services"
1016,2001,1016020011,TwS,baricitinib with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1017,2001,1017020011,TwS,tofacitinib with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1018,2001,1018020011,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services"
1019,2001,1019020011,TwS,adalimumab with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1020,2001,1020020011,TwS,etanercept with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1021,2001,1021020011,TwS,infliximab with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1022,2001,1022020011,TwS,ustekinumab with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1023,2001,1023020011,TwS,Anakinra with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1024,2001,1024020011,TwS,HIV Protease inhibitors with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1025,2001,1025020011,TwS,ritonavir/lopinavir with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1026,2001,1026020011,TwS,Interferon beta 1b with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1027,2001,1027020011,TwS,Interferon beta 1a with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1028,2001,1028020011,TwS,Interferon beta 1a with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1029,2001,1029020011,TwS,favipiravir with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1030,2001,1030020011,TwS,Remdesivir with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1031,2001,1031020011,TwS,ribavirin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1032,2001,1032020011,TwS,oseltamivir with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1033,2001,1033020011,TwS,Ivermectin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1034,2001,1034020011,TwS,itraconazole with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1035,2001,1035020011,TwS,warfarin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1036,2001,1036020011,TwS,heparin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1037,2001,1037020011,TwS,enoxaparin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1038,2001,1038020011,TwS,edoxaban with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1039,2001,1039020011,TwS,dabigatran with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1040,2001,1040020011,TwS,rivaroxaban with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1041,2001,1041020011,TwS,acenocoumarol with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1042,2001,1042020011,TwS,apixaban with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1043,2001,1043020011,TwS,bemiparin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1044,2001,1044020011,TwS,clopidogrel with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1045,2001,1045020011,TwS,aspirin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1046,2001,1046020011,TwS,prasugrel with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1047,2001,1047020011,TwS,alteplase with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1048,2001,1048020011,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services"
1049,2001,1049020011,TwS,tranexamic acid with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1050,2001,1050020011,TwS,Ruxolitinib with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1051,2001,1051020011,TwS,Siltuximab with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1052,2001,1052020011,TwS,ACE inhibitors with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1053,2001,1053020011,TwS,Angiotensin receptor blockers (ARBs) with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1054,2001,1054020011,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1055,2001,1055020011,TwS,Thiazide or thiazide-like diuretics with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1056,2001,1056020011,TwS,Hydrocortisone with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1057,2001,1057020011,TwS,dexamethasone with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1058,2001,1058020011,TwS,prednisone or prednisolone with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1059,2001,1059020011,TwS,raloxifene with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1060,2001,1060020011,TwS,Bevacizumab with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1061,2001,1061020011,TwS,Fingolimod with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1062,2001,1062020011,TwS,eculizumab  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1063,2001,1063020011,TwS,Statins with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1064,2001,1064020011,TwS,metformin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1065,2001,1065020011,TwS,DPP-4 inhibitors with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1066,2001,1066020011,TwS,SGLT2 inhibitors with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1067,2001,1067020011,TwS,GLP1 inhibitors with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1068,2001,1068020011,TwS,H2 receptor antagonist with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1069,2001,1069020011,TwS,famotidine with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1070,2001,1070020011,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services"
1071,2001,1071020011,TwS,prazosin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1072,2001,1072020011,TwS,terazosin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1073,2001,1073020011,TwS,doxazosin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1074,2001,1074020011,TwS,tamsulosin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1075,2001,1075020011,TwS,BCG vaccine with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1076,2001,1076020011,TwS,Colchicine with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1077,2001,1077020011,TwS,Losartan with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1078,2001,1078020011,TwS,cholecalciferol with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1079,2001,1079020011,TwS,Ibrutinib with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1080,2001,1080020011,TwS,abiraterone with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1081,2001,1081020011,TwS,bicalutamide with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1082,2001,1082020011,TwS,emtricitabine with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1083,2001,1083020011,TwS,tacrolimus with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1001,2002,1001020021,TwS,Hydroxychloroquine  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1002,2002,1002020021,TwS,Hydroxychloroquine + Azithromycin  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1003,2002,1003020021,TwS,Hydroxychloroquine + Fluoroquinolones with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1004,2002,1004020021,TwS,Hydroxychloroquine + Amoxicillin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1005,2002,1005020021,TwS,Hydroxychloroquine + ceftriaxone with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1006,2002,1006020021,TwS,Chloroquine with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1007,2002,1007020021,TwS,Azithromycin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1008,2002,1008020021,TwS,Fluoroquinolones with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1009,2002,1009020021,TwS,Amoxicillin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1010,2002,1010020021,TwS,Ceftriaxone with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1011,2002,1011020021,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation"
1012,2002,1012020021,TwS,tocilizumab with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1013,2002,1013020021,TwS,siltuximab with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1014,2002,1014020021,TwS,sarilumab with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1015,2002,1015020021,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation"
1016,2002,1016020021,TwS,baricitinib with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1017,2002,1017020021,TwS,tofacitinib with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1018,2002,1018020021,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation"
1019,2002,1019020021,TwS,adalimumab with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1020,2002,1020020021,TwS,etanercept with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1021,2002,1021020021,TwS,infliximab with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1022,2002,1022020021,TwS,ustekinumab with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1023,2002,1023020021,TwS,Anakinra with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1024,2002,1024020021,TwS,HIV Protease inhibitors with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1025,2002,1025020021,TwS,ritonavir/lopinavir with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1026,2002,1026020021,TwS,Interferon beta 1b with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1027,2002,1027020021,TwS,Interferon beta 1a with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1028,2002,1028020021,TwS,Interferon beta 1a with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1029,2002,1029020021,TwS,favipiravir with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1030,2002,1030020021,TwS,Remdesivir with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1031,2002,1031020021,TwS,ribavirin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1032,2002,1032020021,TwS,oseltamivir with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1033,2002,1033020021,TwS,Ivermectin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1034,2002,1034020021,TwS,itraconazole with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1035,2002,1035020021,TwS,warfarin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1036,2002,1036020021,TwS,heparin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1037,2002,1037020021,TwS,enoxaparin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1038,2002,1038020021,TwS,edoxaban with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1039,2002,1039020021,TwS,dabigatran with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1040,2002,1040020021,TwS,rivaroxaban with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1041,2002,1041020021,TwS,acenocoumarol with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1042,2002,1042020021,TwS,apixaban with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1043,2002,1043020021,TwS,bemiparin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1044,2002,1044020021,TwS,clopidogrel with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1045,2002,1045020021,TwS,aspirin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1046,2002,1046020021,TwS,prasugrel with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1047,2002,1047020021,TwS,alteplase with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1048,2002,1048020021,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation"
1049,2002,1049020021,TwS,tranexamic acid with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1050,2002,1050020021,TwS,Ruxolitinib with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1051,2002,1051020021,TwS,Siltuximab with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1052,2002,1052020021,TwS,ACE inhibitors with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1053,2002,1053020021,TwS,Angiotensin receptor blockers (ARBs) with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1054,2002,1054020021,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1055,2002,1055020021,TwS,Thiazide or thiazide-like diuretics with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1056,2002,1056020021,TwS,Hydrocortisone with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1057,2002,1057020021,TwS,dexamethasone with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1058,2002,1058020021,TwS,prednisone or prednisolone with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1059,2002,1059020021,TwS,raloxifene with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1060,2002,1060020021,TwS,Bevacizumab with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1061,2002,1061020021,TwS,Fingolimod with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1062,2002,1062020021,TwS,eculizumab  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1063,2002,1063020021,TwS,Statins with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1064,2002,1064020021,TwS,metformin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1065,2002,1065020021,TwS,DPP-4 inhibitors with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1066,2002,1066020021,TwS,SGLT2 inhibitors with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1067,2002,1067020021,TwS,GLP1 inhibitors with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1068,2002,1068020021,TwS,H2 receptor antagonist with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1069,2002,1069020021,TwS,famotidine with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1070,2002,1070020021,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation"
1071,2002,1071020021,TwS,prazosin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1072,2002,1072020021,TwS,terazosin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1073,2002,1073020021,TwS,doxazosin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1074,2002,1074020021,TwS,tamsulosin with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1075,2002,1075020021,TwS,BCG vaccine with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1076,2002,1076020021,TwS,Colchicine with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1077,2002,1077020021,TwS,Losartan with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1078,2002,1078020021,TwS,cholecalciferol with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1079,2002,1079020021,TwS,Ibrutinib with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1080,2002,1080020021,TwS,abiraterone with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1081,2002,1081020021,TwS,bicalutamide with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1082,2002,1082020021,TwS,emtricitabine with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1083,2002,1083020021,TwS,tacrolimus with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1001,2003,1001020031,TwS,"Hydroxychloroquine  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1002,2003,1002020031,TwS,"Hydroxychloroquine + Azithromycin  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1003,2003,1003020031,TwS,"Hydroxychloroquine + Fluoroquinolones with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1004,2003,1004020031,TwS,"Hydroxychloroquine + Amoxicillin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1005,2003,1005020031,TwS,"Hydroxychloroquine + ceftriaxone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1006,2003,1006020031,TwS,"Chloroquine with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1007,2003,1007020031,TwS,"Azithromycin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1008,2003,1008020031,TwS,"Fluoroquinolones with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1009,2003,1009020031,TwS,"Amoxicillin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1010,2003,1010020031,TwS,"Ceftriaxone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1011,2003,1011020031,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1012,2003,1012020031,TwS,"tocilizumab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1013,2003,1013020031,TwS,"siltuximab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1014,2003,1014020031,TwS,"sarilumab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1015,2003,1015020031,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1016,2003,1016020031,TwS,"baricitinib with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1017,2003,1017020031,TwS,"tofacitinib with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1018,2003,1018020031,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1019,2003,1019020031,TwS,"adalimumab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1020,2003,1020020031,TwS,"etanercept with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1021,2003,1021020031,TwS,"infliximab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1022,2003,1022020031,TwS,"ustekinumab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1023,2003,1023020031,TwS,"Anakinra with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1024,2003,1024020031,TwS,"HIV Protease inhibitors with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1025,2003,1025020031,TwS,"ritonavir/lopinavir with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1026,2003,1026020031,TwS,"Interferon beta 1b with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1027,2003,1027020031,TwS,"Interferon beta 1a with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1028,2003,1028020031,TwS,"Interferon beta 1a with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1029,2003,1029020031,TwS,"favipiravir with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1030,2003,1030020031,TwS,"Remdesivir with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1031,2003,1031020031,TwS,"ribavirin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1032,2003,1032020031,TwS,"oseltamivir with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1033,2003,1033020031,TwS,"Ivermectin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1034,2003,1034020031,TwS,"itraconazole with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1035,2003,1035020031,TwS,"warfarin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1036,2003,1036020031,TwS,"heparin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1037,2003,1037020031,TwS,"enoxaparin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1038,2003,1038020031,TwS,"edoxaban with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1039,2003,1039020031,TwS,"dabigatran with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1040,2003,1040020031,TwS,"rivaroxaban with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1041,2003,1041020031,TwS,"acenocoumarol with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1042,2003,1042020031,TwS,"apixaban with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1043,2003,1043020031,TwS,"bemiparin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1044,2003,1044020031,TwS,"clopidogrel with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1045,2003,1045020031,TwS,"aspirin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1046,2003,1046020031,TwS,"prasugrel with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1047,2003,1047020031,TwS,"alteplase with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1048,2003,1048020031,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1049,2003,1049020031,TwS,"tranexamic acid with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1050,2003,1050020031,TwS,"Ruxolitinib with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1051,2003,1051020031,TwS,"Siltuximab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1052,2003,1052020031,TwS,"ACE inhibitors with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1053,2003,1053020031,TwS,"Angiotensin receptor blockers (ARBs) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1054,2003,1054020031,TwS,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1055,2003,1055020031,TwS,"Thiazide or thiazide-like diuretics with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1056,2003,1056020031,TwS,"Hydrocortisone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1057,2003,1057020031,TwS,"dexamethasone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1058,2003,1058020031,TwS,"prednisone or prednisolone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1059,2003,1059020031,TwS,"raloxifene with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1060,2003,1060020031,TwS,"Bevacizumab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1061,2003,1061020031,TwS,"Fingolimod with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1062,2003,1062020031,TwS,"eculizumab  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1063,2003,1063020031,TwS,"Statins with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1064,2003,1064020031,TwS,"metformin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1065,2003,1065020031,TwS,"DPP-4 inhibitors with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1066,2003,1066020031,TwS,"SGLT2 inhibitors with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1067,2003,1067020031,TwS,"GLP1 inhibitors with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1068,2003,1068020031,TwS,"H2 receptor antagonist with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1069,2003,1069020031,TwS,"famotidine with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1070,2003,1070020031,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1071,2003,1071020031,TwS,"prazosin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1072,2003,1072020031,TwS,"terazosin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1073,2003,1073020031,TwS,"doxazosin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1074,2003,1074020031,TwS,"tamsulosin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1075,2003,1075020031,TwS,"BCG vaccine with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1076,2003,1076020031,TwS,"Colchicine with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1077,2003,1077020031,TwS,"Losartan with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1078,2003,1078020031,TwS,"cholecalciferol with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1079,2003,1079020031,TwS,"Ibrutinib with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1080,2003,1080020031,TwS,"abiraterone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1081,2003,1081020031,TwS,"bicalutamide with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1082,2003,1082020031,TwS,"emtricitabine with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1083,2003,1083020031,TwS,"tacrolimus with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1001,2004,1001020041,TwS,"Hydroxychloroquine  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1002,2004,1002020041,TwS,"Hydroxychloroquine + Azithromycin  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1003,2004,1003020041,TwS,"Hydroxychloroquine + Fluoroquinolones with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1004,2004,1004020041,TwS,"Hydroxychloroquine + Amoxicillin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1005,2004,1005020041,TwS,"Hydroxychloroquine + ceftriaxone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1006,2004,1006020041,TwS,"Chloroquine with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1007,2004,1007020041,TwS,"Azithromycin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1008,2004,1008020041,TwS,"Fluoroquinolones with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1009,2004,1009020041,TwS,"Amoxicillin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1010,2004,1010020041,TwS,"Ceftriaxone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1011,2004,1011020041,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1012,2004,1012020041,TwS,"tocilizumab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1013,2004,1013020041,TwS,"siltuximab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1014,2004,1014020041,TwS,"sarilumab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1015,2004,1015020041,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1016,2004,1016020041,TwS,"baricitinib with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1017,2004,1017020041,TwS,"tofacitinib with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1018,2004,1018020041,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1019,2004,1019020041,TwS,"adalimumab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1020,2004,1020020041,TwS,"etanercept with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1021,2004,1021020041,TwS,"infliximab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1022,2004,1022020041,TwS,"ustekinumab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1023,2004,1023020041,TwS,"Anakinra with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1024,2004,1024020041,TwS,"HIV Protease inhibitors with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1025,2004,1025020041,TwS,"ritonavir/lopinavir with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1026,2004,1026020041,TwS,"Interferon beta 1b with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1027,2004,1027020041,TwS,"Interferon beta 1a with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1028,2004,1028020041,TwS,"Interferon beta 1a with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1029,2004,1029020041,TwS,"favipiravir with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1030,2004,1030020041,TwS,"Remdesivir with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1031,2004,1031020041,TwS,"ribavirin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1032,2004,1032020041,TwS,"oseltamivir with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1033,2004,1033020041,TwS,"Ivermectin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1034,2004,1034020041,TwS,"itraconazole with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1035,2004,1035020041,TwS,"warfarin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1036,2004,1036020041,TwS,"heparin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1037,2004,1037020041,TwS,"enoxaparin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1038,2004,1038020041,TwS,"edoxaban with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1039,2004,1039020041,TwS,"dabigatran with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1040,2004,1040020041,TwS,"rivaroxaban with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1041,2004,1041020041,TwS,"acenocoumarol with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1042,2004,1042020041,TwS,"apixaban with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1043,2004,1043020041,TwS,"bemiparin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1044,2004,1044020041,TwS,"clopidogrel with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1045,2004,1045020041,TwS,"aspirin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1046,2004,1046020041,TwS,"prasugrel with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1047,2004,1047020041,TwS,"alteplase with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1048,2004,1048020041,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1049,2004,1049020041,TwS,"tranexamic acid with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1050,2004,1050020041,TwS,"Ruxolitinib with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1051,2004,1051020041,TwS,"Siltuximab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1052,2004,1052020041,TwS,"ACE inhibitors with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1053,2004,1053020041,TwS,"Angiotensin receptor blockers (ARBs) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1054,2004,1054020041,TwS,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1055,2004,1055020041,TwS,"Thiazide or thiazide-like diuretics with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1056,2004,1056020041,TwS,"Hydrocortisone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1057,2004,1057020041,TwS,"dexamethasone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1058,2004,1058020041,TwS,"prednisone or prednisolone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1059,2004,1059020041,TwS,"raloxifene with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1060,2004,1060020041,TwS,"Bevacizumab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1061,2004,1061020041,TwS,"Fingolimod with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1062,2004,1062020041,TwS,"eculizumab  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1063,2004,1063020041,TwS,"Statins with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1064,2004,1064020041,TwS,"metformin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1065,2004,1065020041,TwS,"DPP-4 inhibitors with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1066,2004,1066020041,TwS,"SGLT2 inhibitors with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1067,2004,1067020041,TwS,"GLP1 inhibitors with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1068,2004,1068020041,TwS,"H2 receptor antagonist with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1069,2004,1069020041,TwS,"famotidine with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1070,2004,1070020041,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1071,2004,1071020041,TwS,"prazosin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1072,2004,1072020041,TwS,"terazosin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1073,2004,1073020041,TwS,"doxazosin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1074,2004,1074020041,TwS,"tamsulosin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1075,2004,1075020041,TwS,"BCG vaccine with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1076,2004,1076020041,TwS,"Colchicine with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1077,2004,1077020041,TwS,"Losartan with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1078,2004,1078020041,TwS,"cholecalciferol with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1079,2004,1079020041,TwS,"Ibrutinib with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1080,2004,1080020041,TwS,"abiraterone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1081,2004,1081020041,TwS,"bicalutamide with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1082,2004,1082020041,TwS,"emtricitabine with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1083,2004,1083020041,TwS,"tacrolimus with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1001,2005,1001020051,TwS,Hydroxychloroquine  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1002,2005,1002020051,TwS,Hydroxychloroquine + Azithromycin  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1003,2005,1003020051,TwS,Hydroxychloroquine + Fluoroquinolones with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1004,2005,1004020051,TwS,Hydroxychloroquine + Amoxicillin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1005,2005,1005020051,TwS,Hydroxychloroquine + ceftriaxone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1006,2005,1006020051,TwS,Chloroquine with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1007,2005,1007020051,TwS,Azithromycin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1008,2005,1008020051,TwS,Fluoroquinolones with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1009,2005,1009020051,TwS,Amoxicillin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1010,2005,1010020051,TwS,Ceftriaxone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1011,2005,1011020051,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services"
1012,2005,1012020051,TwS,tocilizumab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1013,2005,1013020051,TwS,siltuximab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1014,2005,1014020051,TwS,sarilumab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1015,2005,1015020051,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services"
1016,2005,1016020051,TwS,baricitinib with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1017,2005,1017020051,TwS,tofacitinib with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1018,2005,1018020051,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services"
1019,2005,1019020051,TwS,adalimumab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1020,2005,1020020051,TwS,etanercept with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1021,2005,1021020051,TwS,infliximab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1022,2005,1022020051,TwS,ustekinumab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1023,2005,1023020051,TwS,Anakinra with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1024,2005,1024020051,TwS,HIV Protease inhibitors with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1025,2005,1025020051,TwS,ritonavir/lopinavir with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1026,2005,1026020051,TwS,Interferon beta 1b with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1027,2005,1027020051,TwS,Interferon beta 1a with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1028,2005,1028020051,TwS,Interferon beta 1a with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1029,2005,1029020051,TwS,favipiravir with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1030,2005,1030020051,TwS,Remdesivir with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1031,2005,1031020051,TwS,ribavirin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1032,2005,1032020051,TwS,oseltamivir with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1033,2005,1033020051,TwS,Ivermectin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1034,2005,1034020051,TwS,itraconazole with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1035,2005,1035020051,TwS,warfarin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1036,2005,1036020051,TwS,heparin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1037,2005,1037020051,TwS,enoxaparin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1038,2005,1038020051,TwS,edoxaban with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1039,2005,1039020051,TwS,dabigatran with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1040,2005,1040020051,TwS,rivaroxaban with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1041,2005,1041020051,TwS,acenocoumarol with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1042,2005,1042020051,TwS,apixaban with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1043,2005,1043020051,TwS,bemiparin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1044,2005,1044020051,TwS,clopidogrel with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1045,2005,1045020051,TwS,aspirin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1046,2005,1046020051,TwS,prasugrel with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1047,2005,1047020051,TwS,alteplase with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1048,2005,1048020051,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services"
1049,2005,1049020051,TwS,tranexamic acid with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1050,2005,1050020051,TwS,Ruxolitinib with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1051,2005,1051020051,TwS,Siltuximab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1052,2005,1052020051,TwS,ACE inhibitors with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1053,2005,1053020051,TwS,Angiotensin receptor blockers (ARBs) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1054,2005,1054020051,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1055,2005,1055020051,TwS,Thiazide or thiazide-like diuretics with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1056,2005,1056020051,TwS,Hydrocortisone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1057,2005,1057020051,TwS,dexamethasone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1058,2005,1058020051,TwS,prednisone or prednisolone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1059,2005,1059020051,TwS,raloxifene with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1060,2005,1060020051,TwS,Bevacizumab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1061,2005,1061020051,TwS,Fingolimod with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1062,2005,1062020051,TwS,eculizumab  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1063,2005,1063020051,TwS,Statins with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1064,2005,1064020051,TwS,metformin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1065,2005,1065020051,TwS,DPP-4 inhibitors with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1066,2005,1066020051,TwS,SGLT2 inhibitors with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1067,2005,1067020051,TwS,GLP1 inhibitors with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1068,2005,1068020051,TwS,H2 receptor antagonist with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1069,2005,1069020051,TwS,famotidine with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1070,2005,1070020051,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services"
1071,2005,1071020051,TwS,prazosin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1072,2005,1072020051,TwS,terazosin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1073,2005,1073020051,TwS,doxazosin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1074,2005,1074020051,TwS,tamsulosin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1075,2005,1075020051,TwS,BCG vaccine with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1076,2005,1076020051,TwS,Colchicine with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1077,2005,1077020051,TwS,Losartan with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1078,2005,1078020051,TwS,cholecalciferol with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1079,2005,1079020051,TwS,Ibrutinib with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1080,2005,1080020051,TwS,abiraterone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1081,2005,1081020051,TwS,bicalutamide with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1082,2005,1082020051,TwS,emtricitabine with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1083,2005,1083020051,TwS,tacrolimus with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1001,2006,1001020061,TwS,Hydroxychloroquine  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1002,2006,1002020061,TwS,Hydroxychloroquine + Azithromycin  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1003,2006,1003020061,TwS,Hydroxychloroquine + Fluoroquinolones with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1004,2006,1004020061,TwS,Hydroxychloroquine + Amoxicillin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1005,2006,1005020061,TwS,Hydroxychloroquine + ceftriaxone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1006,2006,1006020061,TwS,Chloroquine with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1007,2006,1007020061,TwS,Azithromycin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1008,2006,1008020061,TwS,Fluoroquinolones with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1009,2006,1009020061,TwS,Amoxicillin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1010,2006,1010020061,TwS,Ceftriaxone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1011,2006,1011020061,TwS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation"
1012,2006,1012020061,TwS,tocilizumab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1013,2006,1013020061,TwS,siltuximab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1014,2006,1014020061,TwS,sarilumab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1015,2006,1015020061,TwS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation"
1016,2006,1016020061,TwS,baricitinib with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1017,2006,1017020061,TwS,tofacitinib with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1018,2006,1018020061,TwS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation"
1019,2006,1019020061,TwS,adalimumab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1020,2006,1020020061,TwS,etanercept with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1021,2006,1021020061,TwS,infliximab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1022,2006,1022020061,TwS,ustekinumab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1023,2006,1023020061,TwS,Anakinra with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1024,2006,1024020061,TwS,HIV Protease inhibitors with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1025,2006,1025020061,TwS,ritonavir/lopinavir with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1026,2006,1026020061,TwS,Interferon beta 1b with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1027,2006,1027020061,TwS,Interferon beta 1a with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1028,2006,1028020061,TwS,Interferon beta 1a with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1029,2006,1029020061,TwS,favipiravir with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1030,2006,1030020061,TwS,Remdesivir with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1031,2006,1031020061,TwS,ribavirin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1032,2006,1032020061,TwS,oseltamivir with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1033,2006,1033020061,TwS,Ivermectin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1034,2006,1034020061,TwS,itraconazole with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1035,2006,1035020061,TwS,warfarin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1036,2006,1036020061,TwS,heparin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1037,2006,1037020061,TwS,enoxaparin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1038,2006,1038020061,TwS,edoxaban with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1039,2006,1039020061,TwS,dabigatran with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1040,2006,1040020061,TwS,rivaroxaban with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1041,2006,1041020061,TwS,acenocoumarol with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1042,2006,1042020061,TwS,apixaban with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1043,2006,1043020061,TwS,bemiparin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1044,2006,1044020061,TwS,clopidogrel with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1045,2006,1045020061,TwS,aspirin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1046,2006,1046020061,TwS,prasugrel with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1047,2006,1047020061,TwS,alteplase with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1048,2006,1048020061,TwS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation"
1049,2006,1049020061,TwS,tranexamic acid with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1050,2006,1050020061,TwS,Ruxolitinib with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1051,2006,1051020061,TwS,Siltuximab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1052,2006,1052020061,TwS,ACE inhibitors with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1053,2006,1053020061,TwS,Angiotensin receptor blockers (ARBs) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1054,2006,1054020061,TwS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1055,2006,1055020061,TwS,Thiazide or thiazide-like diuretics with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1056,2006,1056020061,TwS,Hydrocortisone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1057,2006,1057020061,TwS,dexamethasone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1058,2006,1058020061,TwS,prednisone or prednisolone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1059,2006,1059020061,TwS,raloxifene with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1060,2006,1060020061,TwS,Bevacizumab with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1061,2006,1061020061,TwS,Fingolimod with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1062,2006,1062020061,TwS,eculizumab  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1063,2006,1063020061,TwS,Statins with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1064,2006,1064020061,TwS,metformin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1065,2006,1065020061,TwS,DPP-4 inhibitors with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1066,2006,1066020061,TwS,SGLT2 inhibitors with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1067,2006,1067020061,TwS,GLP1 inhibitors with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1068,2006,1068020061,TwS,H2 receptor antagonist with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1069,2006,1069020061,TwS,famotidine with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1070,2006,1070020061,TwS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation"
1071,2006,1071020061,TwS,prazosin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1072,2006,1072020061,TwS,terazosin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1073,2006,1073020061,TwS,doxazosin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1074,2006,1074020061,TwS,tamsulosin with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1075,2006,1075020061,TwS,BCG vaccine with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1076,2006,1076020061,TwS,Colchicine with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1077,2006,1077020061,TwS,Losartan with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1078,2006,1078020061,TwS,cholecalciferol with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1079,2006,1079020061,TwS,Ibrutinib with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1080,2006,1080020061,TwS,abiraterone with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1081,2006,1081020061,TwS,bicalutamide with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1082,2006,1082020061,TwS,emtricitabine with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1083,2006,1083020061,TwS,tacrolimus with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1001,2001,1001020012,TwoS,Hydroxychloroquine  without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1002,2001,1002020012,TwoS,Hydroxychloroquine + Azithromycin  without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1003,2001,1003020012,TwoS,Hydroxychloroquine + Fluoroquinolones without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1004,2001,1004020012,TwoS,Hydroxychloroquine + Amoxicillin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1005,2001,1005020012,TwoS,Hydroxychloroquine + ceftriaxone without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1006,2001,1006020012,TwoS,Chloroquine without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1007,2001,1007020012,TwoS,Azithromycin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1008,2001,1008020012,TwoS,Fluoroquinolones without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1009,2001,1009020012,TwoS,Amoxicillin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1010,2001,1010020012,TwoS,Ceftriaxone without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1011,2001,1011020012,TwoS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services"
1012,2001,1012020012,TwoS,tocilizumab without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1013,2001,1013020012,TwoS,siltuximab without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1014,2001,1014020012,TwoS,sarilumab without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1015,2001,1015020012,TwoS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services"
1016,2001,1016020012,TwoS,baricitinib without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1017,2001,1017020012,TwoS,tofacitinib without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1018,2001,1018020012,TwoS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services"
1019,2001,1019020012,TwoS,adalimumab without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1020,2001,1020020012,TwoS,etanercept without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1021,2001,1021020012,TwoS,infliximab without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1022,2001,1022020012,TwoS,ustekinumab without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1023,2001,1023020012,TwoS,Anakinra without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1024,2001,1024020012,TwoS,HIV Protease inhibitors without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1025,2001,1025020012,TwoS,ritonavir/lopinavir without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1026,2001,1026020012,TwoS,Interferon beta 1b without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1027,2001,1027020012,TwoS,Interferon beta 1a without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1028,2001,1028020012,TwoS,Interferon beta 1a without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1029,2001,1029020012,TwoS,favipiravir without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1030,2001,1030020012,TwoS,Remdesivir without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1031,2001,1031020012,TwoS,ribavirin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1032,2001,1032020012,TwoS,oseltamivir without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1033,2001,1033020012,TwoS,Ivermectin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1034,2001,1034020012,TwoS,itraconazole without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1035,2001,1035020012,TwoS,warfarin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1036,2001,1036020012,TwoS,heparin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1037,2001,1037020012,TwoS,enoxaparin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1038,2001,1038020012,TwoS,edoxaban without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1039,2001,1039020012,TwoS,dabigatran without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1040,2001,1040020012,TwoS,rivaroxaban without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1041,2001,1041020012,TwoS,acenocoumarol without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1042,2001,1042020012,TwoS,apixaban without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1043,2001,1043020012,TwoS,bemiparin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1044,2001,1044020012,TwoS,clopidogrel without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1045,2001,1045020012,TwoS,aspirin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1046,2001,1046020012,TwoS,prasugrel without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1047,2001,1047020012,TwoS,alteplase without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1048,2001,1048020012,TwoS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services"
1049,2001,1049020012,TwoS,tranexamic acid without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1050,2001,1050020012,TwoS,Ruxolitinib without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1051,2001,1051020012,TwoS,Siltuximab without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1052,2001,1052020012,TwoS,ACE inhibitors without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1053,2001,1053020012,TwoS,Angiotensin receptor blockers (ARBs) without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1054,2001,1054020012,TwoS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1055,2001,1055020012,TwoS,Thiazide or thiazide-like diuretics without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1056,2001,1056020012,TwoS,Hydrocortisone without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1057,2001,1057020012,TwoS,dexamethasone without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1058,2001,1058020012,TwoS,prednisone or prednisolone without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1059,2001,1059020012,TwoS,raloxifene without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1060,2001,1060020012,TwoS,Bevacizumab without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1061,2001,1061020012,TwoS,Fingolimod without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1062,2001,1062020012,TwoS,eculizumab  without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1063,2001,1063020012,TwoS,Statins without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1064,2001,1064020012,TwoS,metformin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1065,2001,1065020012,TwoS,DPP-4 inhibitors without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1066,2001,1066020012,TwoS,SGLT2 inhibitors without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1067,2001,1067020012,TwoS,GLP1 inhibitors without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1068,2001,1068020012,TwoS,H2 receptor antagonist without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1069,2001,1069020012,TwoS,famotidine without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1070,2001,1070020012,TwoS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services"
1071,2001,1071020012,TwoS,prazosin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1072,2001,1072020012,TwoS,terazosin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1073,2001,1073020012,TwoS,doxazosin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1074,2001,1074020012,TwoS,tamsulosin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1075,2001,1075020012,TwoS,BCG vaccine without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1076,2001,1076020012,TwoS,Colchicine without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1077,2001,1077020012,TwoS,Losartan without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1078,2001,1078020012,TwoS,cholecalciferol without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1079,2001,1079020012,TwoS,Ibrutinib without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1080,2001,1080020012,TwoS,abiraterone without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1081,2001,1081020012,TwoS,bicalutamide without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1082,2001,1082020012,TwoS,emtricitabine without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1083,2001,1083020012,TwoS,tacrolimus without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services
1001,2002,1001020022,TwoS,Hydroxychloroquine  without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1002,2002,1002020022,TwoS,Hydroxychloroquine + Azithromycin  without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1003,2002,1003020022,TwoS,Hydroxychloroquine + Fluoroquinolones without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1004,2002,1004020022,TwoS,Hydroxychloroquine + Amoxicillin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1005,2002,1005020022,TwoS,Hydroxychloroquine + ceftriaxone without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1006,2002,1006020022,TwoS,Chloroquine without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1007,2002,1007020022,TwoS,Azithromycin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1008,2002,1008020022,TwoS,Fluoroquinolones without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1009,2002,1009020022,TwoS,Amoxicillin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1010,2002,1010020022,TwoS,Ceftriaxone without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1011,2002,1011020022,TwoS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation"
1012,2002,1012020022,TwoS,tocilizumab without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1013,2002,1013020022,TwoS,siltuximab without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1014,2002,1014020022,TwoS,sarilumab without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1015,2002,1015020022,TwoS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation"
1016,2002,1016020022,TwoS,baricitinib without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1017,2002,1017020022,TwoS,tofacitinib without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1018,2002,1018020022,TwoS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation"
1019,2002,1019020022,TwoS,adalimumab without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1020,2002,1020020022,TwoS,etanercept without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1021,2002,1021020022,TwoS,infliximab without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1022,2002,1022020022,TwoS,ustekinumab without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1023,2002,1023020022,TwoS,Anakinra without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1024,2002,1024020022,TwoS,HIV Protease inhibitors without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1025,2002,1025020022,TwoS,ritonavir/lopinavir without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1026,2002,1026020022,TwoS,Interferon beta 1b without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1027,2002,1027020022,TwoS,Interferon beta 1a without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1028,2002,1028020022,TwoS,Interferon beta 1a without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1029,2002,1029020022,TwoS,favipiravir without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1030,2002,1030020022,TwoS,Remdesivir without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1031,2002,1031020022,TwoS,ribavirin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1032,2002,1032020022,TwoS,oseltamivir without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1033,2002,1033020022,TwoS,Ivermectin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1034,2002,1034020022,TwoS,itraconazole without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1035,2002,1035020022,TwoS,warfarin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1036,2002,1036020022,TwoS,heparin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1037,2002,1037020022,TwoS,enoxaparin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1038,2002,1038020022,TwoS,edoxaban without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1039,2002,1039020022,TwoS,dabigatran without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1040,2002,1040020022,TwoS,rivaroxaban without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1041,2002,1041020022,TwoS,acenocoumarol without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1042,2002,1042020022,TwoS,apixaban without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1043,2002,1043020022,TwoS,bemiparin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1044,2002,1044020022,TwoS,clopidogrel without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1045,2002,1045020022,TwoS,aspirin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1046,2002,1046020022,TwoS,prasugrel without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1047,2002,1047020022,TwoS,alteplase without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1048,2002,1048020022,TwoS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation"
1049,2002,1049020022,TwoS,tranexamic acid without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1050,2002,1050020022,TwoS,Ruxolitinib without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1051,2002,1051020022,TwoS,Siltuximab without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1052,2002,1052020022,TwoS,ACE inhibitors without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1053,2002,1053020022,TwoS,Angiotensin receptor blockers (ARBs) without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1054,2002,1054020022,TwoS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1055,2002,1055020022,TwoS,Thiazide or thiazide-like diuretics without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1056,2002,1056020022,TwoS,Hydrocortisone without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1057,2002,1057020022,TwoS,dexamethasone without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1058,2002,1058020022,TwoS,prednisone or prednisolone without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1059,2002,1059020022,TwoS,raloxifene without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1060,2002,1060020022,TwoS,Bevacizumab without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1061,2002,1061020022,TwoS,Fingolimod without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1062,2002,1062020022,TwoS,eculizumab  without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1063,2002,1063020022,TwoS,Statins without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1064,2002,1064020022,TwoS,metformin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1065,2002,1065020022,TwoS,DPP-4 inhibitors without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1066,2002,1066020022,TwoS,SGLT2 inhibitors without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1067,2002,1067020022,TwoS,GLP1 inhibitors without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1068,2002,1068020022,TwoS,H2 receptor antagonist without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1069,2002,1069020022,TwoS,famotidine without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1070,2002,1070020022,TwoS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation"
1071,2002,1071020022,TwoS,prazosin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1072,2002,1072020022,TwoS,terazosin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1073,2002,1073020022,TwoS,doxazosin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1074,2002,1074020022,TwoS,tamsulosin without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1075,2002,1075020022,TwoS,BCG vaccine without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1076,2002,1076020022,TwoS,Colchicine without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1077,2002,1077020022,TwoS,Losartan without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1078,2002,1078020022,TwoS,cholecalciferol without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1079,2002,1079020022,TwoS,Ibrutinib without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1080,2002,1080020022,TwoS,abiraterone without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1081,2002,1081020022,TwoS,bicalutamide without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1082,2002,1082020022,TwoS,emtricitabine without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1083,2002,1083020022,TwoS,tacrolimus without  with  Persons with a COVID-19 diagnosis record or a SARS-CoV-2 positive test prior to inpatient visit or intensive services and 365d prior observation
1001,2003,1001020032,TwoS,"Hydroxychloroquine  without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1002,2003,1002020032,TwoS,"Hydroxychloroquine + Azithromycin  without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1003,2003,1003020032,TwoS,"Hydroxychloroquine + Fluoroquinolones without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1004,2003,1004020032,TwoS,"Hydroxychloroquine + Amoxicillin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1005,2003,1005020032,TwoS,"Hydroxychloroquine + ceftriaxone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1006,2003,1006020032,TwoS,"Chloroquine without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1007,2003,1007020032,TwoS,"Azithromycin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1008,2003,1008020032,TwoS,"Fluoroquinolones without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1009,2003,1009020032,TwoS,"Amoxicillin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1010,2003,1010020032,TwoS,"Ceftriaxone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1011,2003,1011020032,TwoS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1012,2003,1012020032,TwoS,"tocilizumab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1013,2003,1013020032,TwoS,"siltuximab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1014,2003,1014020032,TwoS,"sarilumab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1015,2003,1015020032,TwoS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1016,2003,1016020032,TwoS,"baricitinib without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1017,2003,1017020032,TwoS,"tofacitinib without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1018,2003,1018020032,TwoS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1019,2003,1019020032,TwoS,"adalimumab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1020,2003,1020020032,TwoS,"etanercept without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1021,2003,1021020032,TwoS,"infliximab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1022,2003,1022020032,TwoS,"ustekinumab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1023,2003,1023020032,TwoS,"Anakinra without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1024,2003,1024020032,TwoS,"HIV Protease inhibitors without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1025,2003,1025020032,TwoS,"ritonavir/lopinavir without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1026,2003,1026020032,TwoS,"Interferon beta 1b without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1027,2003,1027020032,TwoS,"Interferon beta 1a without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1028,2003,1028020032,TwoS,"Interferon beta 1a without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1029,2003,1029020032,TwoS,"favipiravir without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1030,2003,1030020032,TwoS,"Remdesivir without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1031,2003,1031020032,TwoS,"ribavirin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1032,2003,1032020032,TwoS,"oseltamivir without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1033,2003,1033020032,TwoS,"Ivermectin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1034,2003,1034020032,TwoS,"itraconazole without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1035,2003,1035020032,TwoS,"warfarin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1036,2003,1036020032,TwoS,"heparin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1037,2003,1037020032,TwoS,"enoxaparin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1038,2003,1038020032,TwoS,"edoxaban without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1039,2003,1039020032,TwoS,"dabigatran without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1040,2003,1040020032,TwoS,"rivaroxaban without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1041,2003,1041020032,TwoS,"acenocoumarol without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1042,2003,1042020032,TwoS,"apixaban without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1043,2003,1043020032,TwoS,"bemiparin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1044,2003,1044020032,TwoS,"clopidogrel without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1045,2003,1045020032,TwoS,"aspirin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1046,2003,1046020032,TwoS,"prasugrel without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1047,2003,1047020032,TwoS,"alteplase without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1048,2003,1048020032,TwoS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1049,2003,1049020032,TwoS,"tranexamic acid without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1050,2003,1050020032,TwoS,"Ruxolitinib without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1051,2003,1051020032,TwoS,"Siltuximab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1052,2003,1052020032,TwoS,"ACE inhibitors without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1053,2003,1053020032,TwoS,"Angiotensin receptor blockers (ARBs) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1054,2003,1054020032,TwoS,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1055,2003,1055020032,TwoS,"Thiazide or thiazide-like diuretics without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1056,2003,1056020032,TwoS,"Hydrocortisone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1057,2003,1057020032,TwoS,"dexamethasone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1058,2003,1058020032,TwoS,"prednisone or prednisolone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1059,2003,1059020032,TwoS,"raloxifene without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1060,2003,1060020032,TwoS,"Bevacizumab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1061,2003,1061020032,TwoS,"Fingolimod without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1062,2003,1062020032,TwoS,"eculizumab  without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1063,2003,1063020032,TwoS,"Statins without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1064,2003,1064020032,TwoS,"metformin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1065,2003,1065020032,TwoS,"DPP-4 inhibitors without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1066,2003,1066020032,TwoS,"SGLT2 inhibitors without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1067,2003,1067020032,TwoS,"GLP1 inhibitors without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1068,2003,1068020032,TwoS,"H2 receptor antagonist without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1069,2003,1069020032,TwoS,"famotidine without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1070,2003,1070020032,TwoS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1071,2003,1071020032,TwoS,"prazosin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1072,2003,1072020032,TwoS,"terazosin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1073,2003,1073020032,TwoS,"doxazosin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1074,2003,1074020032,TwoS,"tamsulosin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1075,2003,1075020032,TwoS,"BCG vaccine without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1076,2003,1076020032,TwoS,"Colchicine without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1077,2003,1077020032,TwoS,"Losartan without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1078,2003,1078020032,TwoS,"cholecalciferol without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1079,2003,1079020032,TwoS,"Ibrutinib without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1080,2003,1080020032,TwoS,"abiraterone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1081,2003,1081020032,TwoS,"bicalutamide without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1082,2003,1082020032,TwoS,"emtricitabine without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1083,2003,1083020032,TwoS,"tacrolimus without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services"
1001,2004,1001020042,TwoS,"Hydroxychloroquine  without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1002,2004,1002020042,TwoS,"Hydroxychloroquine + Azithromycin  without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1003,2004,1003020042,TwoS,"Hydroxychloroquine + Fluoroquinolones without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1004,2004,1004020042,TwoS,"Hydroxychloroquine + Amoxicillin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1005,2004,1005020042,TwoS,"Hydroxychloroquine + ceftriaxone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1006,2004,1006020042,TwoS,"Chloroquine without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1007,2004,1007020042,TwoS,"Azithromycin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1008,2004,1008020042,TwoS,"Fluoroquinolones without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1009,2004,1009020042,TwoS,"Amoxicillin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1010,2004,1010020042,TwoS,"Ceftriaxone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1011,2004,1011020042,TwoS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1012,2004,1012020042,TwoS,"tocilizumab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1013,2004,1013020042,TwoS,"siltuximab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1014,2004,1014020042,TwoS,"sarilumab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1015,2004,1015020042,TwoS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1016,2004,1016020042,TwoS,"baricitinib without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1017,2004,1017020042,TwoS,"tofacitinib without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1018,2004,1018020042,TwoS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1019,2004,1019020042,TwoS,"adalimumab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1020,2004,1020020042,TwoS,"etanercept without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1021,2004,1021020042,TwoS,"infliximab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1022,2004,1022020042,TwoS,"ustekinumab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1023,2004,1023020042,TwoS,"Anakinra without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1024,2004,1024020042,TwoS,"HIV Protease inhibitors without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1025,2004,1025020042,TwoS,"ritonavir/lopinavir without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1026,2004,1026020042,TwoS,"Interferon beta 1b without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1027,2004,1027020042,TwoS,"Interferon beta 1a without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1028,2004,1028020042,TwoS,"Interferon beta 1a without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1029,2004,1029020042,TwoS,"favipiravir without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1030,2004,1030020042,TwoS,"Remdesivir without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1031,2004,1031020042,TwoS,"ribavirin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1032,2004,1032020042,TwoS,"oseltamivir without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1033,2004,1033020042,TwoS,"Ivermectin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1034,2004,1034020042,TwoS,"itraconazole without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1035,2004,1035020042,TwoS,"warfarin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1036,2004,1036020042,TwoS,"heparin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1037,2004,1037020042,TwoS,"enoxaparin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1038,2004,1038020042,TwoS,"edoxaban without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1039,2004,1039020042,TwoS,"dabigatran without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1040,2004,1040020042,TwoS,"rivaroxaban without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1041,2004,1041020042,TwoS,"acenocoumarol without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1042,2004,1042020042,TwoS,"apixaban without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1043,2004,1043020042,TwoS,"bemiparin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1044,2004,1044020042,TwoS,"clopidogrel without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1045,2004,1045020042,TwoS,"aspirin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1046,2004,1046020042,TwoS,"prasugrel without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1047,2004,1047020042,TwoS,"alteplase without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1048,2004,1048020042,TwoS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1049,2004,1049020042,TwoS,"tranexamic acid without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1050,2004,1050020042,TwoS,"Ruxolitinib without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1051,2004,1051020042,TwoS,"Siltuximab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1052,2004,1052020042,TwoS,"ACE inhibitors without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1053,2004,1053020042,TwoS,"Angiotensin receptor blockers (ARBs) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1054,2004,1054020042,TwoS,"Non-Dihydropyridine Calcium Channel Blocker (ndCCB) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1055,2004,1055020042,TwoS,"Thiazide or thiazide-like diuretics without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1056,2004,1056020042,TwoS,"Hydrocortisone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1057,2004,1057020042,TwoS,"dexamethasone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1058,2004,1058020042,TwoS,"prednisone or prednisolone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1059,2004,1059020042,TwoS,"raloxifene without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1060,2004,1060020042,TwoS,"Bevacizumab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1061,2004,1061020042,TwoS,"Fingolimod without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1062,2004,1062020042,TwoS,"eculizumab  without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1063,2004,1063020042,TwoS,"Statins without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1064,2004,1064020042,TwoS,"metformin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1065,2004,1065020042,TwoS,"DPP-4 inhibitors without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1066,2004,1066020042,TwoS,"SGLT2 inhibitors without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1067,2004,1067020042,TwoS,"GLP1 inhibitors without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1068,2004,1068020042,TwoS,"H2 receptor antagonist without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1069,2004,1069020042,TwoS,"famotidine without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1070,2004,1070020042,TwoS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1071,2004,1071020042,TwoS,"prazosin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1072,2004,1072020042,TwoS,"terazosin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1073,2004,1073020042,TwoS,"doxazosin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1074,2004,1074020042,TwoS,"tamsulosin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1075,2004,1075020042,TwoS,"BCG vaccine without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1076,2004,1076020042,TwoS,"Colchicine without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1077,2004,1077020042,TwoS,"Losartan without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1078,2004,1078020042,TwoS,"cholecalciferol without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1079,2004,1079020042,TwoS,"Ibrutinib without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1080,2004,1080020042,TwoS,"abiraterone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1081,2004,1081020042,TwoS,"bicalutamide without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1082,2004,1082020042,TwoS,"emtricitabine without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1083,2004,1083020042,TwoS,"tacrolimus without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test, inpatient setting without or prior to intensive services and 365d prior observation"
1001,2005,1001020052,TwoS,Hydroxychloroquine  without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1002,2005,1002020052,TwoS,Hydroxychloroquine + Azithromycin  without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1003,2005,1003020052,TwoS,Hydroxychloroquine + Fluoroquinolones without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1004,2005,1004020052,TwoS,Hydroxychloroquine + Amoxicillin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1005,2005,1005020052,TwoS,Hydroxychloroquine + ceftriaxone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1006,2005,1006020052,TwoS,Chloroquine without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1007,2005,1007020052,TwoS,Azithromycin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1008,2005,1008020052,TwoS,Fluoroquinolones without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1009,2005,1009020052,TwoS,Amoxicillin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1010,2005,1010020052,TwoS,Ceftriaxone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1011,2005,1011020052,TwoS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services"
1012,2005,1012020052,TwoS,tocilizumab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1013,2005,1013020052,TwoS,siltuximab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1014,2005,1014020052,TwoS,sarilumab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1015,2005,1015020052,TwoS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services"
1016,2005,1016020052,TwoS,baricitinib without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1017,2005,1017020052,TwoS,tofacitinib without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1018,2005,1018020052,TwoS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services"
1019,2005,1019020052,TwoS,adalimumab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1020,2005,1020020052,TwoS,etanercept without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1021,2005,1021020052,TwoS,infliximab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1022,2005,1022020052,TwoS,ustekinumab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1023,2005,1023020052,TwoS,Anakinra without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1024,2005,1024020052,TwoS,HIV Protease inhibitors without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1025,2005,1025020052,TwoS,ritonavir/lopinavir without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1026,2005,1026020052,TwoS,Interferon beta 1b without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1027,2005,1027020052,TwoS,Interferon beta 1a without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1028,2005,1028020052,TwoS,Interferon beta 1a without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1029,2005,1029020052,TwoS,favipiravir without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1030,2005,1030020052,TwoS,Remdesivir without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1031,2005,1031020052,TwoS,ribavirin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1032,2005,1032020052,TwoS,oseltamivir without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1033,2005,1033020052,TwoS,Ivermectin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1034,2005,1034020052,TwoS,itraconazole without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1035,2005,1035020052,TwoS,warfarin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1036,2005,1036020052,TwoS,heparin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1037,2005,1037020052,TwoS,enoxaparin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1038,2005,1038020052,TwoS,edoxaban without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1039,2005,1039020052,TwoS,dabigatran without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1040,2005,1040020052,TwoS,rivaroxaban without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1041,2005,1041020052,TwoS,acenocoumarol without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1042,2005,1042020052,TwoS,apixaban without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1043,2005,1043020052,TwoS,bemiparin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1044,2005,1044020052,TwoS,clopidogrel without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1045,2005,1045020052,TwoS,aspirin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1046,2005,1046020052,TwoS,prasugrel without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1047,2005,1047020052,TwoS,alteplase without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1048,2005,1048020052,TwoS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services"
1049,2005,1049020052,TwoS,tranexamic acid without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1050,2005,1050020052,TwoS,Ruxolitinib without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1051,2005,1051020052,TwoS,Siltuximab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1052,2005,1052020052,TwoS,ACE inhibitors without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1053,2005,1053020052,TwoS,Angiotensin receptor blockers (ARBs) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1054,2005,1054020052,TwoS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1055,2005,1055020052,TwoS,Thiazide or thiazide-like diuretics without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1056,2005,1056020052,TwoS,Hydrocortisone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1057,2005,1057020052,TwoS,dexamethasone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1058,2005,1058020052,TwoS,prednisone or prednisolone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1059,2005,1059020052,TwoS,raloxifene without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1060,2005,1060020052,TwoS,Bevacizumab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1061,2005,1061020052,TwoS,Fingolimod without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1062,2005,1062020052,TwoS,eculizumab  without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1063,2005,1063020052,TwoS,Statins without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1064,2005,1064020052,TwoS,metformin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1065,2005,1065020052,TwoS,DPP-4 inhibitors without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1066,2005,1066020052,TwoS,SGLT2 inhibitors without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1067,2005,1067020052,TwoS,GLP1 inhibitors without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1068,2005,1068020052,TwoS,H2 receptor antagonist without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1069,2005,1069020052,TwoS,famotidine without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1070,2005,1070020052,TwoS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services"
1071,2005,1071020052,TwoS,prazosin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1072,2005,1072020052,TwoS,terazosin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1073,2005,1073020052,TwoS,doxazosin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1074,2005,1074020052,TwoS,tamsulosin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1075,2005,1075020052,TwoS,BCG vaccine without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1076,2005,1076020052,TwoS,Colchicine without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1077,2005,1077020052,TwoS,Losartan without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1078,2005,1078020052,TwoS,cholecalciferol without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1079,2005,1079020052,TwoS,Ibrutinib without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1080,2005,1080020052,TwoS,abiraterone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1081,2005,1081020052,TwoS,bicalutamide without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1082,2005,1082020052,TwoS,emtricitabine without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1083,2005,1083020052,TwoS,tacrolimus without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services
1001,2006,1001020062,TwoS,Hydroxychloroquine  without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1002,2006,1002020062,TwoS,Hydroxychloroquine + Azithromycin  without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1003,2006,1003020062,TwoS,Hydroxychloroquine + Fluoroquinolones without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1004,2006,1004020062,TwoS,Hydroxychloroquine + Amoxicillin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1005,2006,1005020062,TwoS,Hydroxychloroquine + ceftriaxone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1006,2006,1006020062,TwoS,Chloroquine without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1007,2006,1007020062,TwoS,Azithromycin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1008,2006,1008020062,TwoS,Fluoroquinolones without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1009,2006,1009020062,TwoS,Amoxicillin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1010,2006,1010020062,TwoS,Ceftriaxone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1011,2006,1011020062,TwoS,"IL6 inhibitors (tocilizumab, sarilumab, siltuximab) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation"
1012,2006,1012020062,TwoS,tocilizumab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1013,2006,1013020062,TwoS,siltuximab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1014,2006,1014020062,TwoS,sarilumab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1015,2006,1015020062,TwoS,"JAK inhibitors (ruxolitinib, tofacitinib, oclacitinib, baricitinib, fedratinib, upadacitinib) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation"
1016,2006,1016020062,TwoS,baricitinib without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1017,2006,1017020062,TwoS,tofacitinib without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1018,2006,1018020062,TwoS,"TNF inhibitors (infliximab, golimumab, etanercept, certolizumab pegol, adalimumab) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation"
1019,2006,1019020062,TwoS,adalimumab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1020,2006,1020020062,TwoS,etanercept without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1021,2006,1021020062,TwoS,infliximab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1022,2006,1022020062,TwoS,ustekinumab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1023,2006,1023020062,TwoS,Anakinra without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1024,2006,1024020062,TwoS,HIV Protease inhibitors without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1025,2006,1025020062,TwoS,ritonavir/lopinavir without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1026,2006,1026020062,TwoS,Interferon beta 1b without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1027,2006,1027020062,TwoS,Interferon beta 1a without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1028,2006,1028020062,TwoS,Interferon beta 1a without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1029,2006,1029020062,TwoS,favipiravir without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1030,2006,1030020062,TwoS,Remdesivir without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1031,2006,1031020062,TwoS,ribavirin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1032,2006,1032020062,TwoS,oseltamivir without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1033,2006,1033020062,TwoS,Ivermectin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1034,2006,1034020062,TwoS,itraconazole without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1035,2006,1035020062,TwoS,warfarin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1036,2006,1036020062,TwoS,heparin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1037,2006,1037020062,TwoS,enoxaparin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1038,2006,1038020062,TwoS,edoxaban without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1039,2006,1039020062,TwoS,dabigatran without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1040,2006,1040020062,TwoS,rivaroxaban without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1041,2006,1041020062,TwoS,acenocoumarol without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1042,2006,1042020062,TwoS,apixaban without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1043,2006,1043020062,TwoS,bemiparin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1044,2006,1044020062,TwoS,clopidogrel without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1045,2006,1045020062,TwoS,aspirin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1046,2006,1046020062,TwoS,prasugrel without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1047,2006,1047020062,TwoS,alteplase without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1048,2006,1048020062,TwoS,"Antifibrinolytics (tranexamic acid, aminocaproic acid) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation"
1049,2006,1049020062,TwoS,tranexamic acid without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1050,2006,1050020062,TwoS,Ruxolitinib without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1051,2006,1051020062,TwoS,Siltuximab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1052,2006,1052020062,TwoS,ACE inhibitors without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1053,2006,1053020062,TwoS,Angiotensin receptor blockers (ARBs) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1054,2006,1054020062,TwoS,Non-Dihydropyridine Calcium Channel Blocker (ndCCB) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1055,2006,1055020062,TwoS,Thiazide or thiazide-like diuretics without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1056,2006,1056020062,TwoS,Hydrocortisone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1057,2006,1057020062,TwoS,dexamethasone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1058,2006,1058020062,TwoS,prednisone or prednisolone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1059,2006,1059020062,TwoS,raloxifene without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1060,2006,1060020062,TwoS,Bevacizumab without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1061,2006,1061020062,TwoS,Fingolimod without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1062,2006,1062020062,TwoS,eculizumab  without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1063,2006,1063020062,TwoS,Statins without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1064,2006,1064020062,TwoS,metformin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1065,2006,1065020062,TwoS,DPP-4 inhibitors without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1066,2006,1066020062,TwoS,SGLT2 inhibitors without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1067,2006,1067020062,TwoS,GLP1 inhibitors without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1068,2006,1068020062,TwoS,H2 receptor antagonist without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1069,2006,1069020062,TwoS,famotidine without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1070,2006,1070020062,TwoS,"Alpha-1 blockers (Doxazosin, prazosin, terazosin, tasulosin, silodosin, alfuzosin) without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation"
1071,2006,1071020062,TwoS,prazosin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1072,2006,1072020062,TwoS,terazosin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1073,2006,1073020062,TwoS,doxazosin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1074,2006,1074020062,TwoS,tamsulosin without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1075,2006,1075020062,TwoS,BCG vaccine without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1076,2006,1076020062,TwoS,Colchicine without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1077,2006,1077020062,TwoS,Losartan without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1078,2006,1078020062,TwoS,cholecalciferol without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1079,2006,1079020062,TwoS,Ibrutinib without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1080,2006,1080020062,TwoS,abiraterone without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1081,2006,1081020062,TwoS,bicalutamide without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1082,2006,1082020062,TwoS,emtricitabine without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
1083,2006,1083020062,TwoS,tacrolimus without  with  Persons hospitalized with a COVID-19 diagnosis record or a SARS-CoV-2 positive test after intensive services with 365d prior observation
